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Summary 
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SUMMARY 
 
The intracellular trafficking allows dynamic flux of proteins and lipids between 
different compartments. This is largely mediated by the budding of vesicles from a donor 
compartment, followed by their transport to an acceptor compartment membrane and 
subsequent fusion. Nevertheless, tubular transport still has to be considered as an additional 
mode of transport throughout the cell. 
The SNARE-proteins have been characterized as playing an essential role in docking 
and fusion events occurring between two organelles. Four α-helices from SNARE-proteins 
form a stable, parallel four-helix bundle that facilitates lipid bilayer fusion. The first SNARE 
complex to be identified was the synaptic complex. A SNARE-complex homologous to the 
synaptic complex has been shown to be involved in Golgi-to-ER retrograde transport in yeast. 
By homology with this complex, we assumed the participation of the following SNAREs in 
Golgi-to-ER traffic in mammalian cells: mSec22b as the R-SNARE, Syntaxin18, mUse1 and 
mSec20 as the three Q-SNAREs. Even though this putative retrograde Golgi-ER SNARE-
complex does not follow the “1R-3Q rule” previously defined for other SNARE-complexes, 
the data obtained here by live cell fluorescence measurements (FRET and BiFC) and 
coimmunoprecipitation showed that the addressed mammalian SNARE-homologs indeed 
form a SNARE-complex. 
 The cellular machinery for COPI-dependent Golgi-to-ER retrograde transport 
regulates the exit of specific cargo from the Golgi to the ER. The KDEL receptor Erd2 is 
known to cycle between the Golgi and the ER following the COPI-pathway. It serves the 
continuous recycling of escaped ER proteins which contain a KDEL motif at their C- 
terminus. Using live cell FRET measurements, mSec22b, mUse1 and mSec20 were found to 
individually interact with Erd2. Moreover, the combination of a cell-free budding assay for 
Golgi-derived vesicles with immuno-electron microscopy revealed the presence of mSec22b 
and mUse1 in COPI-coated vesicles. Additionally, mUse1 antibodies co-precipitated β´-COP 
(a COPI-subunit) as well as KDEL-R. Finally, using the cholera toxin (CTX) as an external 
KDEL-protein, I was able to show that the down-regulation of mSec22b using siRNA disturbs 
Golgi-to-ER retrograde transport.  
In summary, my results strongly suggest the involvement of the SNAREs mSec22b, 
mUse1, mSec20 and Syntaxin18 in various steps of the retrograde Golgi-to-ER transport in 
mammalian cells.   
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1. INTRODUCTION 
 
1.1. The intracellular traffic 
& 
The secretory apparatus within all eukaryotic cells comprises a dynamic membrane 
system with multidirectional membrane transport pathways and overlapping compartmental 
boundaries. Thirty years ago, the work of George Palade and colleagues [1] on protein 
secretion established that newly synthesized secretory proteins pass through a series of 
membrane-enclosed organelles, including the endoplasmic reticulum (ER), the Golgi 
complex, and secretory granules, on their way to the extracellular space where they are 
released (figure 1). Proteins destined for residence at the plasma membrane, within 
endosomes, or within lysosomes, share the early stations of this pathway with secretory 
proteins. 
  
Figure 1. Intracellular pathways (Bonifacino and Glick, 2004). The scheme depicts the compartments of the 
secretory, lysosomal/vacuolar, and endocytic pathways. Arrows indicate transport steps and colors show the 
known or presumed locations of COPII (blue), COPI (red), and clathrin (orange). Clathrin coats are 
heterogeneous and contain different adaptor and accessory proteins at different membranes. Only the functions 
of COPII (in ER export) and of plasma membrane-associated clathrin (in endocytosis) are known with certainty. 
Less well understood are the exact functions of COPI at the ERGIC and Golgi complex and of clathrin at the 
TGN, early endosomes, and immature secretory granules. The pathway of transport through the Golgi stack is 
generally believed to involve a combination of COPI-mediated vesicular transport and cisternal maturation [2]. 
 
The basic eukaryotic secretory apparatus consists of a transport machinery that 
performs three fundamental tasks: (i) sorting and concentration of secretory products for exit 
out of the ER; (ii) changes in composition of membrane-bound transport intermediates; and 
(iii) regulated fusion of transport intermediates with target membranes.  
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The transport of proteins can be mediated by distinct vesicles as well as by continuous 
tubular connections (such as between the ER and the Golgi complex). Many aspects of 
secretory traffic vary considerably in different cell types (e.g. the roles of cytoskeletal 
elements and the sizes, shape, and location of organelles). Nevertheless, intracellular transport 
and sorting events work similarly for most of them. Intracellular traffic is rapid and very 
selective, with some carriers only needing seconds to transport a selected subset of proteins 
and lipids from the donor membrane to the acceptor organelle, thus preventing the 
homogenization of membrane components and permitting the maintenance of cellular 
organization.  
Compartmental specificity is provided by distinct members of protein families, such as 
those involved in sorting (e.g. membrane coats, adaptor proteins, and cargo receptors; [3, 4]) 
and membrane fusion (Rabs, SNARES; [5, 6]). The compartment-specific docking is likely 
accomplished by facilitating the interaction between members of the docking/fusion 
machinery, the t-SNARES and v-SNARES [7], an interaction that in some cases can be 
inhibited by another family of proteins, the Sec1 proteins [8, 9]. Together with the other 
members of the docking/fusion machinery (NSF/SNAP;[10]), these molecular components 
regulate fusion and assembly of membranes and establish trafficking patterns. 
 
1.1.1. Vesicular transport 
 
How are the secretory proteins transported in the different pathways? As they are often 
found within small, membrane-enclosed vesicles present among the major organelles of the 
pathway [11], the vesicular transport hypothesis was put forward, stating that the transfer of 
cargo molecules between organelles of the secretory pathway is mediated by shuttling 
transport vesicles. According to this hypothesis, vesicles form from a donor compartment 
(budding) by a process that allows selective incorporation of cargo into the forming vesicles 
while retaining resident proteins in the donor compartment (protein sorting). The vesicles are 
subsequently targeted to a specific acceptor compartment (vesicle targeting), into which they 
unload their cargo upon fusion of their limiting membranes (vesicle fusion). 
The processes of budding and fusion are repeated in the consecutive transport steps 
until the cargo reaches its final destination within or outside the cell. To balance this forward 
movement of cargo, organelle homeostasis requires the retrieval of transport machinery 
components and escaped resident proteins from the acceptor compartments back to the 
corresponding donor compartments (retrograde transport), a process that is also proposed to 
occur mainly by vesicular transport [12, 13]. All of these steps are tightly regulated and 
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balanced so that a large amount of cargo can flow through the secretory pathway without 
compromising the integrity and steady-state composition of the constituent organelles. 
Interestingly, yeast and mammals share conserved vesicular transport machineries [14, 15]. 
The best-studied traffic pathways are those that use carrier vesicles that are clearly 
identifiable by their coats, made of the coatomer COPI, of COPII, or of clathrin and its 
partners. However, the possible existence of a transport mediated by tubular structures cannot 
be excluded. 
 
1.1.2. Tubular transport 
 
Although budding of vesicles is widely believed to occur from ER exit sites [1, 16, 
17]), ultrastructural studies have shown these sites sometimes consist of permanent/ 
intermittent connections with the ERGIC (ER-Golgi Intermediate Compartment) or with the 
first cisternae of the Golgi stack itself [13, 18]. This indicates that the boundary separating the 
ER from the rest of the secretory pathway is not always distinct and that export of protein out 
of the ER does not necessarily rely on the production of small vesicles. It however, depends 
on energy since all protein export out of the ER ceases in the absence of ATP, or when 
energy-coupled regulatory molecules are inactivated or depleted [19, 20].  
The same holds for the intra-Golgi transport. The standard view of Golgi traffic is that 
it is mediated primarily by vesicles that pinch off from one cisterna and then become targeted 
to and fuse with a different cisterna [21]. Unidirectional transport of protein and lipid is thus 
achieved with no intermixing of donor and acceptor compartments. Besides the vesicles, 
tubule connections between Golgi stacks are frequently observed in electron micrographs [22, 
23] and the cis - and trans- most cisternae of the Golgi complex appear to be composed of 
extensive tubular (50-100nm diameter) networks [24, 25]. Tubules can be rapidly generated 
by Golgi membranes in vivo and in vitro under various conditions [26, 27].  
Membrane traffic has been shown to be mediated by tubules extending between organelles in 
cells expressing GFP tagged markers or/and treated with the drug brefeldin A (BFA). BFA 
blocks membrane export out of the ER in vivo [28, 29] and inhibits vesicle formation both in 
vivo [30] and in vitro [31]. This is likely due to BFA’s inhibition of nucleotide exchange onto 
ADP-ribosylation factor (ARF), a low–molecular weight GTPase [32], by which this BFA 
prevents assembly of cytosolic coat proteins (including COPI components) onto target 
membranes [31]. At the same time, extensive retrograde transport of Golgi components to the 
ER, mediated by growth of Golgi tubules, occurs with BFA treatment, leading to the complete 
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loss of Golgi structure [33]. Whether the formation of tubular structures reflects what occurs 
under normal physiological conditions, is a matter of discussion.  
Other structures that do not have COP or clathrin coats have been observed in the cell. 
Internalization from the plasma membrane can also occur via macropinocytosis, phagocytosis 
and probably through caveolae [34]. In the secretory pathway, poorly understood tubular 
structures connect the Golgi with the plasma membrane and the ER [35, 36]. In the endocytic 
pathway, tubules emerge from early endosomes and participate in recycling to the plasma 
membrane [37]. These carrier structures tend to be heterogeneous and in some cases, they 
might be used for large-scale movement of selectively captured membrane components [38, 
39]. Other organelles appearing like elongated vesicles could act in Golgi traffic, migrate 
within the cytoplasm or translocate along microtubules to their target membranes, 
unidirectionally and without causing mixing. They could also establish connections between 
the same or different compartments but certain mechanisms would be necessary to maintain 
chemically distinct compartments and to achieve directed transport of protein and lipid. 
Recently, other carriers called large pleiomorphic carriers (LPCs) have been described 
as responsible for moving the bulk of the secretory traffic between distant compartments. 
LPCs are much larger and more variable in shape than vesicles, and they have evident 
interconnected tubular and saccular/cisternal components. The process of formation of LPC 
and its function need to be further characterized [40]. 
 
1.2. Role of the coat-proteins : focus on COPI-vesicles 
 
The budding of transport vesicles and the selective incorporation of cargo into the forming 
vesicles are both mediated by protein coats [41, 42]. These coats are supramolecular 
assemblies of proteins that are recruited from the cytosol to the budding vesicles.  
The first group of reactions forms the initiation step; it leads to the specific recruitment of 
coat components to the corresponding donor membrane. This step is energy dependent and 
includes sorting of cargo to the forming coat. Coat propagation, the second step in the 
process, couples further addition of coat components and additional recruitment of cargo with 
invagination of the underlying membrane. When formation of the coat ends, the vesicle buds 
by scission of the neck connecting the invaginated membrane to the donor surface. Finally, by 
a process of uncoating, the coat components are released so that membrane fusion can occur 
between the uncoated vesicle and the target organelle (Figure 2).  
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Figure 2. Steps of vesicle budding and fusion (Bonifacino and Glick, 2004). This scheme shows the different 
proteins involved in the vesicular transport machinery (1) Initiation. The membrane-proximal coat components 
(blue) are recruited to the donor compartment by binding to a membrane-associated GTPase (red). 
Transmembrane cargo proteins and SNAREs begin to concentrate at the assembly coat. (2) Budding. The 
membrane-distal coat components (green) are recruited and polymerize. Simultaneously, cargo gets concentrated 
and membrane curvature increases. (3) Scission. The neck between the vesicles and the donor compartment is 
severed either by direct action of the coat (for COPI- and COPII-coated vesicles) or by accessory proteins (for 
clathrin-coated vesicles). (4) Uncoating. The vesicle loses its coat partly due to inactivation of a small specific 
GTPase, phosphoinositide hydrolysis, and the action of uncoating enzymes. Cytosolic coat proteins are then 
recycled for additional rounds of vesicle budding. (5) Tethering. The "naked" vesicle moves to the acceptor 
compartment, possibly guided by the cytoskeleton, and becomes tethered to the acceptor compartment by the 
combination of a GTP bound Rab and a tethering factor. (6) Docking. The v- and t-SNAREs assemble into a 
four-helix bundle. (7) Fusion. This "trans-SNARE complex" promotes fusion of the vesicle and acceptor lipid 
bilayers. Cargo is transferred to the acceptor compartment, and the SNAREs are recycled. 
 
The coats also participate in cargo selection and concentration by recognizing sorting 
signals present in the cytoplasmic domains of transmembrane cargo proteins. During the 
formation of a vesicle, coat proteins carry out sequential interactions that lead to budding 
from the donor membrane, uncoating, fusion with a target membrane and recycling of the coat 
components. Different coats and specific sorting signals mediate vesicle budding and cargo 
selection at different stages of the exocytic and endocytic pathways. 
Cell-free systems have been useful in demonstrating transport of proteins from various 
donor organelles to acceptor organelles. They have been used to identify various proteins 
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required for formation of different transport vesicles and to study their function, their 
targeting to appropriate organelles, and their fusion with acceptor membranes.  
The first coats to be identified and characterized contained a scaffold protein, clathrin, as 
their main constituent [43]. Clathrin coats were initially assumed to participate in most 
vesicular transport steps within the cell. However, later studies demonstrated that the function 
of these coats was restricted to post-Golgi locations including the plasma membrane, the 
trans-Golgi network (TGN), and endosomes. Non-clathrin coats, called COPII and COPI, 
were later discovered to be involved in vesicular transport in the early secretory pathway [16, 
44] (see chapter 1.5.). There are clear similarities and differences between the ways that 
COPI, COPII and clathrin coats handle these steps [41, 42]. The coat proteins surrounding 
many other types of transport vesicles have not been identified yet. This is the case for 
instance for those moving from late endosomes to lysosomes or the constitutive secretory 
vesicles that move proteins from the trans-Golgi to the plasma membrane. 
 
The COPI-coatomer complex was first isolated from cytosol of bovine brain. It is present 
in all eukaryotic cells examined so far, including Drosophila and yeast. The COPI coat has 
been localized to the ERGIC, along the cis face of the Golgi, and associated with the rims of 
subsequent cisternae [45, 46]. The discovery of a membrane-bound form of coatomer on 
Golgi derived transport vesicles was the first hint for a role of this complex in intracellular 
trafficking. 
The COPI coatomer (700kDa) is a cytoplasmic complex of seven protein subunits: α-
COP, β-COP, β’-COP, γ-COP, δ-COP, є-COP and ζ-COP [47]. In S.cerevisiae, homologues 
of α-, β-, β’- and γ-COP are the products of the genes RET4, SEC26, SEC27 and SEC21, 
respectively. The primary structure of α- and β’-COP presents four or five WD-40 repeated 
motifs (a conserved ~ 40 amino acids stretch terminating with the residues Trp, Asp), 
respectively. WD-40 repeats are typically found in β-subunits of trimeric G proteins but also 
in other subunits of various hetero-oligomeric protein complexes. This motif might represent 
an oligomerization motif or might be involved in the binding of coatomer to membranes. 
Interestingly, β-COP, δ-COP and ζ-COP show weak homologies to subunits of the adaptin 
complexes of clathrin-coated vesicles. Similar to the clathrin-coated vesicle, they act as a 
bridge between the cytosolic tails of membrane proteins and the fibrous cage that surrounds 
the vesicles; they also mediate the specific incorporation of proteins into these coated 
vesicles. Like COPII, COPI recognizes specific signals in the cytoplasmic domains of 
transmembrane cargo proteins, although in this case the signals function to retrieve proteins 
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from the ERGIC or the Golgi complex to the ER [48, 49]. γ-COP seems to be the component 
responsible for cargo recognition because it recognizes the cytoplasmic carboxyterminal 
domain sorting signals KKXX (the dilysine motif) or KXKXX (X is any amino acid). Finally, 
є-COP is not related to any known protein.  
The KDEL receptor, a 7-fold-spanning membrane protein that binds and retrieves lumenal 
proteins containing the KDEL carboxy-terminal sequence, is transported along the COPI 
pathway (though it is not known whether it is recognized by the γ subunit) [50]. Additional 
constituents of the COPI-coated transport intermediates are the p24 family proteins, which are 
type I transmembrane proteins that have been proposed to function in both cargo selection and 
coat recruitment [51]. 
Figure 4. COPI-vesicles 
assembly and uncoating 
(Kirchhausen T., 2000). 
Coat assembly is activated by 
the recruitment of ARF1-GTP 
to the membrane. This allows 
the binding of the COPI 
coatomer and the recruitment 
of cargo. Membrane 
deformation occurs at the 
same time as coat 
recruitment. When the coat is 
complete, the vesicle buds. 
The GTPase activity of ARF1 
is enhanced by ARF1-GAP leading to inactivation of ARF1 and uncoating. (ARF1, ADP-ribosylation factor 1; 
ARF1-GAP, ADP-ribosylation factor 1 GTPase activating protein; ARF1GEF, ADP-ribosylation factor 1 
guanine exchange factor.) 
 
The initial event in the COPI pathway that leads to recruitment of the coat requires the 
association of the GTPase ARF1 (ADP-ribosylation factor 1) in its active GTP-bound form to 
the membrane. ARF1 is myristoylated to allow its membrane association. In the GTP-bound 
state, the myristoyl group is exposed and ARF1 becomes membrane bound. When the GTP is 
hydrolyzed, the protein undergoes a conformational change, developing a myristoyl-binding 
pocket that covers the tail, solubilizing the protein. The GDP-GTP exchange is regulated by a 
Golgi-associated GTPase-activating protein, ARF-GAP [52] which apparently receives and 
integrates multiple signals from the cytosol, such that the amount of ARF-GTP, and thus the 
rate of formation of COPI vesicles is appropriate to the needs of the cell. Recent studies 
  11 
 Introduction 
___________________________________________________________________________ 
indicate that this activity is also required for cargo sorting and budding [53, 54]. During COPI 
coat assembly, ARF-GTP simultaneously recruits the membrane-proximal βγδζ and the 
membrane-distal αβ’є subcomplexes [47], contrary to the stepwise assembly of COPII. ARF1 
and the COPII-associated small GTPase Sar1p are closely related [32, 55]. But unlike Sar1p, 
ARF proteins have many effectors, including COPI and other coats as well as lipid-modifying 
enzymes [56]. The ARF protein family consists of several members, and targeting of ARF1 to 
the correct membrane involves specific association with its appropriate GEF. Several GEFs 
for ARF1 have been identified, one of which (known as ARF1GEF, ARNO3 or GRP1) seems 
to be specifically associated with the COPI pathway [57]. Many different GEFs and GAPs 
activate and inactivate ARF binding, respectively, in an effector- or compartment-specific 
fashion [56]. Once the COPI vesicles are released from the donor membrane, the COPI coat 
dissociates. This step is triggered by the hydrolysis of the GTP bound to ARF proteins in the 
vesicles; accordingly when COPI vesicles are formed in vitro in the presence of a non 
hydrolysable GTP analog, the COPI coats do not dissociate [58].  
It has been suggested that hydrolysis of GTP and release of ARF1 from the membrane act 
as a timer, triggering (as with Sar1p and COPII vesicles) the release of the other coat 
components and preparing the vesicle for fusion with its target membrane. The rate at which 
ARF1 hydrolyses GTP depends on its association with ARF-GAP and the COPI complex 
[59], both of which are required for full GTPase activation. Recently, it has been shown that 
vesicles that capture preferred cargo (such as the FFXXRRXX sorting signal containing p24 
protein hp24a [60]) will retain their ARF1 protein long enough to complete coat assembly, 
whereas vesicles that capture other proteins will not. In other words, GTP hydrolysis is slow 
when ARF1 is bound to its preferred cargo, allowing kinetic regulation of coat recruitment. 
 
1.3. Structure and function of the SNARE-proteins 
 
Despite the variety of coat proteins that mediate formation of transport vesicles, fusion of 
all vesicles with their target membranes exhibits several common features. In all cases, fusion 
occurs after the coats have depolymerized and seems to involve a conserved set of proteins 
that (a) mediates targeting of vesicles to the appropriate fusion partner and (b) triggers the 
fusion process itself. Fusion and part of targeting reactions rely on so called SNARE-proteins 
[61]. 
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1.3.1. Discovery of the SNAREs 
 
An early contribution of the cell-free intra-Golgi transport assay was the identification of 
an “N-ethylmaleimide-Sensitive Factor” (NSF), which could exist in cytoplasmic or 
membrane bound forms [62]. Accumulation of uncoated vesicles on Golgi membranes was 
observed by electron microscopy when NSF was inactivated, implying that NSF is required 
for membrane fusion [63]. The yeast ortholog of NSF, Sec18p, had been implicated in ER-to-
Golgi transport [64]. It became soon apparent, that NSF is involved in a wide range of 
membrane fusion steps in the secretory and endocytic pathways [65, 66]. NSF forms a 
homohexameric ring [67] and is a founding member of the AAA protein family (“ATPases 
associated with diverse cellular activities”), a group of enzymes that catalyze the structural 
remodeling of protein complexes [68]. α-SNAP (“soluble NSF association protein”), the 
mammalian ortholog of Sec17p [15], was identified as a binding partner for NSF, which links 
NSF to membranes [10]. Using NSF/α-SNAP as an affinity reagent to fractionate a brain 
lysate, Söllner and colleagues identified a set of three membrane-associated “SNAP 
Receptors,” or SNAREs [61], which had previously been implicated in linking synaptic 
vesicles to the plasma membrane [69]. One of them, Synaptobrevin, was known to be 
associated with synaptic vesicles, whereas the other two, Syntaxin and SNAP-25, had been 
localized to the presynaptic plasma membrane. The data suggested the presence in the Golgi 
of synaptic SNARE-proteins homologs which could bind NSF/α-SNAP and be related to 
membrane fusion events. 
 
1.3.2. Definition and structural features 
 
The SNAREs represent a superfamily of proteins that is thought to play a key role in most 
of intracellular membrane fusion events within eukaryotes [5, 7, 70, 71]. SNAREs are 
generally small proteins of around 100–300 amino acids in length. They possess homologous 
domains of approximately 60 amino acids referred to as the “SNARE motif” [72, 73]. Most 
SNAREs contain only one SNARE motif near the C-terminal tail anchor or the C-terminus, 
but 3 of them (SNAP-23, SNAP-25, and SNAP-29) contain two tandem SNARE motifs 
separated by a linker region. 36 distinct SNAREs are known in mammalian cells [74, 75] and 
most of them (31) are C-terminally anchored transmembrane proteins, with their functional N-
terminal domains facing the cytosol. The other five SNAREs (SNAP-23, SNAP-25, SNAP-
29, Syn11, and Ykt6) are instead attached to the membrane by prenylation (Ykt6) [76], 
palmitoylation of Cys residues (SNAP-25, Ykt6, and Syn11) [76-78], and/or interaction with 
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other SNAREs that are anchored by C-terminal tails [79]. Most SNAREs are also 
characterized by an extended N-terminal domain with coiled-coil regions (for review see 
[80]).  
Certain sets of SNARE proteins form stable complexes through assembly of their SNARE 
motifs into a parallel four-helix coiled-coil structure [70, 81]. The best characterized SNARE 
complex is the one mediating exocytosis of synaptic vesicles in neurons. A crystal structure of 
the neuronal SNARE complex consisting of synaptobrevin-II (VAMP2), syntaxin 1A, and 
SNAP-25B revealed a four-helix bundle. The four helices are connected by 16 layers of 
interacting surfaces mediated by the side chains of the residues which are mostly hydrophobic 
and are arranged perpendicular to the axis of the four-helical bundle. The middle of the 
bundle is usually characterized by a layer (defined as the 0 layer) of interaction mediated by 
hydrophilic residues: three Gln (Q) (contributed one each by Syntaxin1 and the N- and C- 
terminal parts of SNAP25 called S25N and S25C respectively), and one Arg (R) (contributed 
by VAMP2) [73, 82]. 
 
Fig 4: Crystal structure of a 
synaptic trans-SNARE complex 
drawn after Sutton et al.[82]. The 
structures of the two membrane 
anchors and of the peptide that 
links the two SNAP-25 α-helices 
are hypothetical. 
 
 
SNAREs are thus structurally classified as Q-SNAREs and R-SNAREs dependent on 
the presence of either Q or R at this position, with the Q-SNAREs further divided into Qa (for 
Syntaxin subfamily), Qb (for S25N subfamily), and Qc (for S25C subfamily) SNAREs [73]. 
It is now generally believed that one member of each subfamily contributes a single SNARE 
motif, resulting in the Qa:Qb:Qc:R configuration of a SNARE complex. Solution of the 
crystal structure of an endosomal SNARE complex consisting of the SNARE domains of 
Syn7 (Qa), Vti1b (Qb), Syn8 (Qc), and VAMP8 (R) supports this stoichiometric principle 
derived from analysis of the neuronal SNARE complex [83]. The ionic layer seems to be a 
conserved feature of many different SNARE complexes and consists in most cases of one 
arginine residue contributed by an R-SNARE and three glutamine residues contributed by 
three Q-SNARE helices [73]. However, recent studies show the existence of SNARE 
complexes formed between an R-SNARE, 2 Q-SNAREs and a fourth SNARE helix carrying 
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an aspartate or a serine in its zero layer such as ER-to-Golgi [84] and Golgi-to-ER [85] 
SNARE complexes in yeast and the early endosomal SNARE complex in mammals [83].  
The current concept of the action of SNAREs is that the combinatory use of the 
various members of the Qa-, Qb-, Qc-, and R-SNAREs gives rise to a wide array of SNARE 
complexes, whose functions are determined in part by the subcellular targeting of newly-made 
uncomplexed SNAREs. The composition of many complexes is not known with certainty in 
mammalian cells [86, 87] while defined SNARE complexes can be assigned to most fusion 
steps in yeast [88-90]. Some SNAREs participate in several fusion events with different 
partners, such as the yeast R-SNARE Ykt6p, the mammalian Qa-SNARE Syntaxin5 and the 
yeast Qb-SNARE Vti1p. A SNARE complex mediating a specific fusion reaction may also 
accept alternative SNAREs such as Ykt6p which can substitute for Nyv1p in traffic to the 
vacuole [91] and for Sec22p in the fusion of COPII-vesicles with the Golgi [92]. 
Although SNAREs are structurally distinguished as Q-SNAREs or R-SNAREs, they can 
be functionnally classified into v-SNAREs that are associated with the vesicle/container and t-
SNAREs that are associated with the target compartment; this classification, however, is less 
meaningfull when considering homotypic fusion of organelles. There is a rough 
correspondence of R-SNAREs with v-SNAREs and of Q-SNAREs with t-SNAREs. A major 
insight from structural analysis of the SNARE complexes was that v- and t-SNAREs pair in a 
parallel way [82, 93, 94]. During vesicular transport, the vesicle as it buds from the donor 
organelle, incorporates a v-SNARE which is uncovered when the vesicle coat proteins 
depolymerize. The specific v-SNARE targets the transport carrier to its correct membrane 
fusion partner which contains one or more t-SNAREs. These t-SNAREs act cooperatively to 
specifically bind a particular v-SNARE.  
Fig 5: The SNARE cycle (Bonifacino 
and Glick, 2004). A trans-SNARE 
complex assembles when a monome-
ric v-SNARE on the vesicle binds to 
an oligomeric t-SNARE on the target 
membrane, forming a stable four-helix 
bundle that promotes fusion. The 
result is a cis-SNARE complex in the 
fused membrane. α-SNAP binds to 
this complex [95] and recruits NSF, 
which hydrolyzes ATP to dissociate 
the complex. Unpaired v-SNAREs can 
then be packaged into vesicles again.  
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Specific interaction between v-SNARE and t-SNARE leads to the formation of the trans-
SNARE complex (or SNAREpin) [86, 96, 97]. The SNARE motifs are believed to be 
‘‘unstructured’’ before complex assembly and become highly organized into a twisted parallel 
four-helical bundle during the formation of the trans-SNARE complex. This conformation 
persists throughout the fusion reaction to become a cis-SNARE complex in the fused 
membrane (Figure 5). α-SNAP then binds the SNARE complex [95] and recruits the ATPase 
NSF. Interaction of NSF and three α-SNAPs with the cis-SNARE complex leads to the 
formation of a transient 20 S complex [98, 99]. ATP hydrolysis by NSF leads to the 
disassembly of the 20 S complex as well as the cis-SNARE complex [100]. The freed v-
SNAREs can then be recycled to the donor compartment by retrograde transport, while the t-
SNARE subunits can be re-organized into functional t-SNAREs for the next round of docking 
and fusion events. 
The formation of the trans-SNARE complex generates the energy needed to bring the two 
negatively charged apposing membranes close enough to fuse. Indeed, the trans-SNARE 
complex with its hydrophobic segments in two apposing membrane bilayers is structurally 
analogous to the activated form of viral fusion proteins and could act as fusogen [96]. The 
idea that SNAREs act as fusogens was supported by experiments demonstrating that two 
populations of liposomes containing either v- or t- purified recombinant SNAREs can fuse 
[101]. A similar effect was shown with cells engineered to produce either v- or the cognate t- 
“flipped” SNAREs facing the outside of the cell rather than the cytoplasm [102]. In both 
cases, fusion was observed suggesting that SNAREs form the conserved, essential core of the 
fusion machinery.  
SNAREs also help to ensure the compartmental specificity of membrane fusion [86, 103, 
104]. Different v-/t-SNARE complexes form at different steps of intracellular transport. 
Surprisingly, purified SNAREs can pair promiscuously in vitro but when used in the liposome 
fusion assay they form almost exclusively physiologically relevant trans-SNARE 
complexes[103], providing an assay to predict SNARE complexes that form in vivo [105]. 
However, SNAREs alone cannot be the only components determining the specificity of 
membrane fusion because a given v-SNARE recycles and is therefore present in both 
anterograde and retrograde vesicles (Figure 5). Additional specificity is provided by tethering 
proteins that link the apposing membranes prior to SNARE complex formation. These various 
tethers assemble with the aid of Rab family GTPases (known as Ypt proteins in yeast) to 
promote the initial association of two membranes [96, 106] (Figure 2).  
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All newly-made SNAREs are first delivered to their hosting compartment(s) via the 
secretory and endocytic pathways. Little is known about how SNAREs are targeted to specific 
organelles. For the few SNAREs examined so far, targeting determinants are present in the 
transmembrane sequence, the cytosolic domain, or both [107]. An important mechanism for 
SNARE localization and possibly for vesicle formation is direct interaction with vesicle coats. 
For example, SNAREs involved in ER-to-Golgi transport must be packaged into COPII 
vesicles during ER export and then into COPI vesicles during retrieval from the Golgi [108, 
109]. Recent biochemical and structural studies have shown how three S. cerevisiae SNAREs 
involved in ER-to-Golgi transport, Sed5p, Bet1p, and Sec22p, interact with the COPII coat 
[110, 111]. Distinct sites on the Sec24p subunit seem to bind selectively the uncomplexed, 
fusogenic forms of the SNAREs [111]. Similarly, Vti1b interacts with epsinR [112], and 
VAMP2 was suggested to have a role in rapid endocytosis of synaptic vesicles [113]. Thus, 
SNAREs could also have a role in vesicle budding additionally to their role in vesicle fusion. 
  
1.4. Accessory and regulatory proteins  
 
Biochemical in vitro studies (such as liposome fusion assays) demonstrate that SNARE 
complexes are sufficient to mediate vesicle fusion. However, the fusion event is much faster 
in vivo implying that additional components cooperate with SNAREs [101] and regulate 
fusion.  
Although NSF and α-SNAP represent the most essential regulators of SNAREs, other 
proteins preventing inappropriate SNARE complex formation are required for regulation of 
vesicle fusion [114]. For instance, following fusion of two membranes and dissociation of the 
cis-SNARE complex by NSF/α-SNAP, the SNAREs need to be kept inactive until the next 
round of fusion. This is done by cytosolic factors such as GATE-16 and LMA1 which bind 
the individual v- and t-SNAREs and help to keep them separate [115].  
Post-translational modifications such as phosphorylation [116-119], palmitoylation [76-
78], and prenylation [76, 120] are also likely to regulate the function of SNAREs or of 
interacting components [114]. Key regulatory elements for SNARE complex assembly are 
present in the SNAREs themselves as seen previously (the N-terminal three-helix bundle of 
syntaxins or longin domain of members of the synaptobrevin family; [121]) but they can also 
come from other factors. In some cases, trans-SNARE complex assembly seems to be 
arrested at an intermediate stage, with accessory proteins preventing the complete “zipping 
up” of the four-helix bundle until a fusion signal is received [86]. The best candidate for such 
an accessory protein is the putative Ca2+ sensor synaptotagmin, which triggers the 
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complexin-stabilized trans-SNARE complex and promotes synaptic vesicle fusion in response 
to Ca2+ influx [96, 122]. Complexins are small cytosolic proteins (134 residues) found in 
neuronal (complexin I) as well as non-neuronal (complexin II) tissues. Binding of complexins 
to the SNARE complex competes with binding of α-SNAP, indicating that complexins are 
involved in regulation of membrane fusion [123]. Complexins are proposed to complete the 
Munc13-1/2-mediated priming process of tethered synaptic vesicles at the presynaptic plasma 
membrane [97]. The tethering of synaptic vesicles is regulated by Rab3 and its effector RIM1 
[97]. Further components have been shown to affect SNARE function in synaptic vesicles by 
inhibiting the formation of a fusogenic SNARE complex (synaptophysin [97], tomosyn and 
amisyn [124, 125]. 
Another important group of SNARE-interacting proteins is the SM family, whose 
founding members are the yeast SEC1 gene product [126] and neuronal Munc-18. Each 
membrane fusion step requires a specific SM protein [127]. These proteins bind to syntaxins, 
but the mode of binding is not conserved, and various SM proteins either stimulate or inhibit 
SNARE complex assembly.  
There are at least seven mammalian members of the SM protein family: Munc18-1, Munc18-
2, and Munc18-3, VPS33A, VPS33B, VPS45, and SLY1. The Munc18 isoforms are 
functionally homologous to yeast Sec1p and function at the plasma membrane. They bind to 
the closed conformation of Syntaxins 1 to 4. This interaction depends on both the N-terminal 
Habc region and the SNARE motif of Syntaxins [128]. VPS33A and VPS33B correspond to 
yeast Vps33p and act in the endocytic pathway but they seem to serve unique functions [129, 
130]. VPS45 and SLY1 correspond to yeast Vps45p and Sly1p, respectively, and are involved 
in traffic at the trans- and cis-faces of the Golgi apparatus [131]. SLY1 and VPS45 interact 
with a short N-terminal region of Syntaxins 5 and 18 and Syn16, respectively, without the 
involvement of the Habc region or the SNARE motif [132, 133].  
A class of small GTPases called Rab proteins participates in the control of vesicular 
traffic in eukaryotic cells. They are found on transport intermediates where they regulate 
directional movement along microtubules [134] and control the rate of specific fusion [9, 
135]. They have an overall structure similar to Ras and, like Ras, purified Rab proteins bind 
and hydrolyze GTP. Specifically, a cytosolic protein called GEF catalyzes the exchange of 
GDP, bound to cytosolic Rab, for GTP, inducing a conformational change in Rab which can 
then bind to a surface protein on a particular transport vesicle. After vesicle fusion occurs, the 
GTP bound to the Rab protein is hydrolyzed to GDP, triggering the release of the Rab protein, 
which then can undergo another cycle.  
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Several lines of evidence support the involvement of specific Rab proteins as timers of 
specific vesicle fusion events. For instance, Rab5 is localized to early endosomes, and it 
regulates the sorting endosome via several downstream effectors [136]. Homotypic fusion of 
early endosomes requires the presence of Rab5 and its rate is increased when adding Rab5 
and GTP to cell-free extracts suggesting that Rab5·GTP acts as a timer for vesicle fusion. 
Similarly, Rab1 (the mammalian homolog of the yeast protein Ypt1) is essential for ER-to-
Golgi transport reactions to occur in cell-free extracts, while Rab5 or Rab7 are not. Thus, 
some individual Rab proteins are essential for specific vesicle fusion reactions to occur.  
Various tethering factors [137, 138] are also involved in fusion events. They position the 
vesicles precisely at the region of the target compartment where the t-SNAREs are located. 
The tethering factors act over a longer distance than the SNAREs and interact with both the 
vesicle and the target compartment to facilitate the subsequent pairing of the v-SNARE with 
the cognate t-SNARE. The heteromeric “quatrefoil” tethers are exemplified by the exocyst, 
which links secretory carriers to the plasma membrane [139]. Six of the original sec mutants 
defined different subunits of the exocyst [140]. Related quatrefoil tethers function in Golgi 
traffic; for example, the COG complex is believed to mediate the tethering of COPI vesicles 
to Golgi cisternae [138, 141]. Also, p115 is a tethering factor that functions by simultaneous 
interaction with giantin on COPI-generated vesicles and with GM130 on the cis-Golgi [142]. 
A SNARE-related coiled-coil region of p115 interacts with many SNAREs of the Golgi 
apparatus (Syn5, GS28, GS27, Ykt6, GS15, Bet1, Sec22b), suggesting that p115 modulates 
the formation of trans-SNARE complexes such as Syn5-GS28-GS15-Ykt6 and Syn5-GS27-
Bet1-Sec22b involved in intra-Golgi transport [143]. Like p115, Hrs (endosome-associated 
hepatocyte responsive serum phosphoprotein) contains a SNARE-like coiled-coil region 
which is shown to inhibit the incorporation of an R-SNARE into the SNARE complex 
through competitive binding to a t-SNARE complex. Through this activity, Hrs inhibits early 
endosomal fusion mediated by Syn13, SNAP-25, and VAMP2 [144]. Other similar coiled-coil 
tethers called golgins are present in the Golgi [145]. A different type of tether is EEA1 which 
acts as a Rab5 effector that promotes the homotypic fusion of early endosomes [146].  
More generally, an interaction of members of the SM and Rab families with SNAREs 
might add an additional layer of specificity or serve as a proofreading mechanism to vesicle 
docking and fusion. Together with tethers, they collaborate to ensure that membranes fuse at 
the correct time and place. Thus, like many biological processes, membrane fusion employs 
sequential, partially redundant mechanisms to achieve high fidelity.  
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1.5. Golgi –ER cycle 
 
Protein transport from the ER to the Golgi occurs in both forward (anterograde) and 
backward (retrograde) directions. Proteins are transported via the anterograde pathway from 
the ER to the Golgi, where ER resident proteins are specifically captured in a receptor-
dependent manner and retrieved via the retrograde pathway [48, 147-150]. In Saccharomyces 
cerevisiae, more than 15 genes have been identified that are required for membrane traffic 
between the ER and Golgi complex [151]. Mammalian homologues for many of these genes 
have been identified biochemically by the use of cell-free systems [10, 65, 152], and through 
cloning based on sequence similarity with known yeast genes. At least two vesicular coat 
protein complexes, COPI and COPII, are involved in transport between the ER and Golgi 
complex [21, 151]. Strong data from yeast genetics and biochemical studies has led to a 
simple transport model, in which COPII vesicles mediate unidirectional ER-to-Golgi transport 
and COPI vesicles mediate intra-Golgi and Golgi-to-ER transport [153, 154], maintaining 
selected molecules within the ER/Golgi system [149, 155]. A putative post-ER-pre-Golgi 
compartment,  designated the intermediate compartment (IC) or ER-to-Golgi IC (ERGIC), 
was discovered in the early 90s and has been proposed to be a distinct organelle separated 
from the ER and Golgi by two vesicular transport steps [156]. In this view, COPII was 
suggested to mediate ER-to-ERGIC transport, COPI would mediate ERGIC-to-Golgi 
transport [157] and a modified COPI complex would return the transport machinery back to 
the donor membranes [158]; alternatively, additional vesicular coat complexes that remain to 
be identified might exist and be involved in traffic between the ER and Golgi complex.  
 
1.5.1. The Endoplasmic reticulum 
 
The ER is the port of entry for all membrane proteins and proteins entering into the 
secretory pathway. It engages in lipid biosynthesis and metabolism, as well as in protein 
import, post-translational modifications (which include protein folding, oligomerisation and 
covalent modifications such as glycosylation and disulfide bonds formation) and degradation 
[159]. The synthesis and translocation of proteins as well as the release of properly processed, 
folded and assembled proteins that are transported to their destinations [160], are mainly 
performed by three sets of specific resident ER components. The translocation machinery 
transports the nascent chain of a growing polypeptide through the ER membrane. In 
mammalian cells translocation occurs predominantly co-translationally but sometimes post-
translationally (e.g. probably for the SNAREs, which do not contain a signal sequence). The 
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translocation site is composed of membrane proteins that target the ribosome-bound nascent 
chain to the cytoplasmic face of the ER membrane, and of proteins that form an ER-
membrane channel through which the polypeptide is translocated. On the lumenal site of the 
ER membrane, an oligosaccharyl transferase catalyzes co-translational N-glycosylation of 
most polypeptides. Molecular chaperones are present as soluble proteins in the lumen of the 
ER (such as BiP/grp74 and calreticulin) or in a membrane-bound form facing the lumen of the 
ER (such as calnexin). Chaperones associate with nascent chains or with the polypeptide after 
its release from the ribosome in order to control and facilitate proper folding and assembly of 
the newly synthesized protein. A third major group of ER resident proteins comprises folding 
enzymes (such as e.g. protein disulfide isomerase and peptidyl-prolyl cis-trans isomerase) 
that assist the proper folding of newly synthesized proteins. Wrongly folded proteins are 
rapidly degraded in the ER by a lumenal-ER associated degradation apparatus known as 
ERAD (ER Associated Degradation) [161]. 
 
The ER is comprised of an extensive array of interconnecting membrane tubules and 
cisternae which usually extend throughout the cell [162]. The specialized lumenal 
environment of the ER, which is oxidizing (promoting disulfide bond formation) with high 
ATP and free calcium levels, enable protein folding and assembly of proteins and lipids from 
monomeric (low energy) forms to multimeric (higher energy) complexes. 
Protein export from the ER occurs only when a protein is properly folded and assembled 
and takes place in specialized regions of the ER, devoid of ribosomes, called ER exit sites [16, 
163, 164]. They arise spontaneously throughout the ER [165] and are adjacent to clusters of 
elaborate membrane tubules/vesicles constituting the IC [166] (also called VTC, Vesicle 
Tubular Clusters; [17], pre-Golgi intermediates; [165, 167]). Although budding of vesicles is 
widely believed to occur from ER exit sites [1, 16, 17], ultrastructural studies have shown that 
ER exit sites sometimes consist of permanent/ intermittent connections with the IC or with the 
first cisternae of the Golgi stack itself [13, 18, 168, 169].  
 
1.5.2. The Golgi apparatus 
 
While studying nerve cells stained by the metal-impregantion technique, Camillo 
Golgi discovered a basket-like network surrounding the nucleus in Purkinje cells. A detailed 
description of this structure called Golgi complex was later provided by electron microscopy 
(for review see [170]). It revealed a typical stack of 3-8 flattened cisternae which is 
morphologically and functionally polarised (in the cis to trans direction). The Golgi stack, 
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including the cis-Golgi, the medial (middle) saccules, and the trans saccules [170, 171], 
carries out post-translational processing of newly synthesized proteins and the enzymes 
involved in these modifications are arranged across the stack in the order in which they 
function: for instance, phosphorylation occurs in the cis region, while in other regions, 
different types of carbohydrates (like mannose or galactose) are added as a glycoprotein 
passes through the cisternae [172]. To this ensemble, come two flanking tubular networks of 
membrane [173]; the cis-Golgi network (CGN) and the trans-Golgi network (TGN). The 
CGN comprises vesicular and tubular extensions that may be connected with the first 
cisternae of the Golgi stack and is located on the entry side of the stack; its role is not only to 
receive material from the ER but also to participate in the sorting and recycling of proteins 
and lipids back to the ER. The TGN forms a sacculotubular network extending from the trans 
cisternae and constitutes the sorting station of the Golgi. It has been suggested that the TGN 
itself is composed of functionally distinct subdomains containing glycosylation enzymes 
(such as sialyl transferase), as well as enzymes that perform late Golgi modifications (such as 
tyrosine sulfation). They might also be involved in the segregation of membrane and lumenal 
proteins into different types of transport vesicles destined for endosomes, lysosomes, 
secretory granules and the plasma membrane. Certain proteins also stay in the Golgi serving 
in a permanent bidirectional intra-Golgi transport. Thus, the Golgi apparatus appears as a 
dynamic structure being the main crossroad of the intracellular trafficking; nevertheless, there 
is an enrichment of lipids and proteins which is constantly maintained from the cis to the 
trans compartment. It remains unclear how the different Golgi cisternae interrelate, whether 
they are stable or not, or what is the exact function of the numerous vesicles and 
uncharacterized tubules that are always associated with the Golgi apparatus [174].  
 
1.5.3. The Intermediate Compartment 
 
The intracellular trafic between the ER and the Golgi in mammalian cells appears to 
be complicated due to the existence of the IC which is absent in Saccharomyces cerevisiae. 
The IC has been defined biochemically by marker proteins, most notably ERGIC53, and 
morphologically by the piling up of secretory proteins in this compartment at reduced 
temperature: at 15°C, proteins are segregated into tubulo-vesicular structures that are distinct 
from the typical ER [175]. After its formation, the IC has only a transient existence before 
delivering its cargo to the Golgi complex in a process involving simultaneously forward 
secretory transport and Golgi biogenesis. Since its identification [156], it has been matter of 
debate whether the IC is continuous with the ER [176] or the cis-Golgi [173] or is a distinct 
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organelle separated from the ER and Golgi [156, 177]. In line with the latter, it has been 
postulated that small vesicles bud from the IC to deliver cargo into the Golgi complex [178] 
or to recycle proteins back to the ER.  
Live cell timelapse imaging following different GFP-tagged secretory markers (e.g. 
VSVG-GFP; vesicular stomatitis virus G glycoprotein) revealed that the ERGIC is a mobile 
membrane structure which carries protein and lipid along microtubules from the ER to the 
Golgi complex [165, 179]; therefore it was called vesicular-tubular transport complex (VTC). 
VTCs have also been shown to undergo maturation (by recycling of selected components 
back to the ER; [180]) and to be capable of homotypic fusion [181]. This would fit the 
hypothesis that the Golgi cisternae form by continuous maturation/ differentiation of VTCs 
[182, 183]. In this model, the cis face of the Golgi complex represents the site where VTCs 
first merge together, while the trans face is where they have to undergo further maturation 
through recycling pathways [184-186].  
 
1.5.4. Retrograde pathways 
 
1.5.4.1. COPI dependent and independent transport pathways  
The continous flow of membrane from the ER to the Golgi apparatus would finally 
lead to a depletion of ER membranes and to a steady extension of the Golgi complex. 
Therefore, in order to maintain the functional and structural identity of the endomembrane 
system, lipids and proteins must be recycled. At least two retrograde transport routes have 
been described to be operative in the early pathway. They serve several important functions 
such as the retrieval of escaped endoplasmic reticulum (ER) proteins [12, 187] and membrane 
machinery necessary for ER-to-Golgi traffic [188, 189], retention of misfolded proteins [190, 
191], recycling of Golgi enzymes [192, 193], the internalization of bacterial and plant toxins 
[194], and the disassembly of the Golgi complex during mitosis[195].  
Among these, the recycling of ER residents has been particularly well studied. During 
normal anterograde flow a certain number of endogenous ER proteins continuously leave the 
organelle and reach downstream compartments in the secretory pathway where they are 
recognized and returned back to their original location [12]. Soluble ER proteins such as 
chaperones and components of the quality control machinery contain a C-terminal KDEL 
(HDEL in yeast) sequence that is responsible for their recognition and retrieval from post-ER 
compartments [196, 197]. Through their association with molecular chaperones misfolded 
proteins are also efficiently recovered from post-ER compartments and rerouted to the ER 
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[198]. Many ER transmembrane proteins contain a dilysine (KKXX) motif at their C-terminal 
cytoplasmic tail which is also a retrieval signal [199, 200]. In addition to KDEL and KKXX 
sorting signals, retrieval of these proteins depends on receptors that recognize these signals. 
The role of such receptors is to ensure that there is no net loss of these proteins from the ER. 
The ligand-receptor complexes are transported back to the ER where they dissociate leading 
to the release of ligand within the ER and subsequently the empty receptor can be recycled 
back to the Golgi for further rounds of transport. The affinity between ligand and receptor has 
been suggested to depend on the pH which is different between the ER and the Golgi [201]. 
The KDEL motif is recognized by Erd2 (or KDEL receptor) which is located at the Golgi 
complex and the ERGIC [202].COPI-coated transport intermediates, believed to be either 
vesicles or tubules [186, 203, 204], mediate retrograde traffic followed by both the KDEL 
receptor-ligand complexes and membrane proteins containing a KKXX motif [48, 149, 158, 
165]. The A-subunit of Cholera toxin (CTX) which contains a KDEL motif in its C-term is 
thought to move from Golgi to ER by COPI-dependent transport [205, 206] (see chapter 
1.5.4.3.).Upon ligand binding the KDEL receptor oligomerizes and interacts with components 
of the retrograde transport machinery such as ARF-GAP and ARF1 [207], most likely 
contributing to the formation at the donor membrane of prebudding complexes that should 
facilitate evagination. In principle, sorting takes place through the interaction of COPI coat 
proteins with the cytoplasmic domains of the KDEL receptor [49, 157]. For example, the 
phosphorylation by cAMP-dependent protein kinase A (PKA) of the C-terminal cytoplasmic 
domain of the mammalian KDEL receptor seems to favor this interaction of the KDEL 
receptor with coatomer proteins and ARF-GAP [208].  
Another, COPI independent, recycling pathway was claimed to be used by the Shiga toxin 
or Shiga Toxin B-fragment and to be regulated by Rab6 [209, 210]. Expression of a dominant 
negative Rab6 form (Rab6-GDP) inhibited redistribution of GFP-tagged Golgi-resident 
enzymes to the ER [210], which suggests that these enzymes use this or a closely related 
Rab6-dependent pathway to gain access to the ER. Co-localisation of Shiga-B fragment and 
GFP-tagged Rab6 on larger tubular structures that do not contain the KDEL-R seems to 
support these functional studies [209]. These tubules segregate from the Golgi and are 
believed to fuse with the ER at the cell periphery.  
Experiments using GFP-tagged KDEL receptor expressed in HeLa cells showed similar 
formation of Golgi tubules and subsequent detachment and translocation of these tubules to 
the cell periphery [204]. These data suggest that both tubular and vesicular carriers could 
mediate Golgi-to-ER transport. Importantly, in every case, the tubules could be observed as a 
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result of overexpression of GFP-tagged markers. However, such tubules were also found in 
untransfected cells by both fluorescence microscopy and immunoelectron microscopy [211]. 
Interestingly, the effects of the fungal antibiotic brefeldin A (BFA) have been taken as 
evidence for the existence of a physiologically relevant retrograde pathway from the Golgi to 
the ER. BFA reversibly blocks transport of secretory proteins to the Golgi apparatus, and 
induces a dramatic fusion of most of the Golgi membrane with the ER. Treatment of many 
mammalian cells with BFA leads to an immediate dissociation of Golgi-bound COPI-coats 
into the cytoplasm resulting in the formation of tubular structures which eventually separate 
from the Golgi and fuse with the ER [212]. However, a fundamental function of coatomer 
seems to be the prevention of uncontrolled fusion. Thus, BFA-induced dissociation of 
coatomer would allow uncontrolled fusion of Golgi with ER membranes rather than 
retrograde transport. 
Recently, Malsam and collaborators [213] demonstrated the existence of subpopulations 
of COPI vesicles defined by their tethering factors (p115 versus golgin84-CASP). These 
tethers may differentiate the intra-Golgi and Golgi-ER retrograde COPI vesicles. This work 
also suggested a two-step retrograde pathway for the Golgi enzymes, the first step mediated 
by intra-Golgi COPI transport to the CGN, the second by a COPI-independent pathway to the 
ER. Tubular continuities were previously proposed to mediate the retrograde transport of 
Golgi enzymes, leaving COPI vesicles to carry the fusion machinery [214].  
 
In principle, vesicles or tubules could also form from the ERGIC in mammalian cells. It 
has been proposed that a VTC receives cargo from COPII vesicles followed by the exchange 
of COPII for COPI leading to COPI vesicles which would return recycling material from the 
ERGIC to the ER [179, 215]. Upon arrival at the cis-Golgi, anterograde cargo must physically 
segregate from retrograde cargo in order to be delivered for further transit through the 
secretory pathway, whereas retrograde cargo must be returned back to the ER. Establishment 
of retrograde- and anterograde-cargo domains [216] was observed within the VTC itself on its 
way to the cis-Golgi.  
1.5.4.2. Golgi-ER SNAREs 
Several SNARE complexes have been defined to function in various transport events 
in the secretory and/ or endocytic pathways of mammalian cells. The complex consisting of 
Syn5 (Qa), membrin (Qb), Bet1 (Qc), and Sec22b (R) described by Xu et al. [217] as 
involved in ER to Golgi transport appears to function in mediating homotypic fusion of ER-
derived COPII vesicles to form the IC or VTCs [189, 218]. This SNARE complex has a 
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corresponding yeast homolog formed by Sed5p, Bos1p, Bet1p and Sec22p respectively. The 
SNARE complex consisting of Syn5 (Qa), GS28 (Qb), Bet1 (Qc), and Ykt6 (R) is suggested 
to act in the late stage of transport from the ER to the Golgi and is likely to mediate the fusion 
of matured VTCs with the cis-face of the Golgi apparatus [219]. The SNARE complex 
consisting of Syn5 (Qa), GS28 (Qb), GS15 (Qc), and Ykt6 (R) functions in intra-Golgi traffic 
and a similar complex is also found in yeast [105, 220, 221]. Sec22p has been shown to 
interact with syntaxin 18, the mammalian homologue of Ufe1 [222]. Moreover, in yeast 
Sec22p recycles from the Golgi back to the ER and this recycling involves retrograde COPI 
vesicles and the ER transmembrane proteins Ufe1p and Sec20p [223]. Recently, Dilcher et al. 
demonstrated the existence of an unconventionnal SNARE in the ER called Use1 (also called 
Slt1, [224]) in yeast which interacts with the SNAREs Ufe1p, myc-Sec20p and Sec22p 
forming a SNARE complex required for Golgi-to-ER retrograde traffic in yeast [85].  
Similar to the interaction of yeast Sec20p with its regulator TIP20 [225], the 
mammalian Sec20 (also called BNIP) interacts with RINT-1, a mammalian protein 
homologous to TIP20 [226, 227]. The two SNARE-proteins Sec22 and Ykt6 exhibit a 
profilin-like structure in their N-terminal extension [228, 229]. Interestingly, the same domain 
is found in the Trs20/SEDL subunit of the TRAPP complex, which is involved in the 
tethering process in the early secretory pathway [230]. This raises the possibility that this 
tethering complex could modulate the function of SNAREs containing profilin-domain 
through competitive interaction with some unidentified regulators. 
1.5.4.3. The cholera toxin as external cargo protein  
Cholera toxin (Ctx) from Vibrio cholerae is one of the well-characterized virulence 
factors produced by pathogenic micro-organisms and belongs to the group of so called AB5-
toxins composed of one A-subunit and five identical B-subunits noncovalently associated 
[231]. Studies on its interaction, uptake and action in epithelial cells have helped to elucidate 
the mechanisms of toxicity. These toxins move from the plasma membrane through the trans-
Golgi and endoplasmic reticulum (ER) to the cytoplasm of host cells. Therefore, they 
constitute convenient tools to better understand cellular events associated with vesicular 
movement and targeting.  
Cholera toxin begins its journey into the cell by the binding of its B-subunits to the 
gangliosides GM1 at the cell surface [232] resulting in the association of Ctx with lipid rafts 
[233, 234], which are required for toxin function [235, 236] and found ubiquitously on the 
surface of eukaryotic cells [237]. Cholera toxin has been reported to enter cells from non-
coated areas of the surface membrane [238], possibly from caveolae [236]. Following 
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internalization, it can be found in early and recycling endosomes, the Golgi apparatus and the 
ER [205, 239]. There is evidence to suggest that the A- and B-subunits of the Ctx separate in 
the Golgi apparatus and that only the A-subunit containing a KDEL motif in its C-term then 
moves to the ER by binding the KDEL receptor, ERD2 [206, 239]. However, the KDEL motif 
seems not to be required for toxin function [240], although it improves the efficiency of 
intoxication [241]. Additionally, recent studies show that the lipid-raft ganglioside, GM1, is 
responsible for transport into these compartments [240]. Nevertheless, there is evidence to 
suggest that Ctx might move backwards from the Golgi to ER by COPI-dependent transport 
[205, 206]. This COPI-dependent pathway might also carry lipid-raft gangliosides back to the 
ER. Once in the ER, the A1-chain of the Ctx unfolds and enters the cytoplasm by hijacking 
the cellular machinery that enables misfolded proteins to cross the membrane for degradation, 
a process termed retro-translocation [242]. Upon entering the cytoplasm, the A1-chain rapidly 
refolds, avoids the proteasome and induces toxicity by ADP-ribosylating the α subunit of 
various heterotrimeric G-proteins [231, 243, 244]. This ADP-ribosylation is stimulated by 
ARF and activates adenylyl cyclase; this induces intestinal chloride secretion that causes the 
massive secretory diarrhea seen in cholera.  
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2. AIM OF THIS WORK 
 
 The aim of this work was to characterize the SNARE complex(es) involved in Golgi-
to-ER traffic and to elucidate a potential role of SNARE-proteins in cargo sorting and 
budding. By homology with the synaptic SNARE complex and on the basis of previous 
studies in yeast, we assumed the participation of the following SNARE-proteins in Golgi-to-
ER traffic: Sec22b as the R-SNARE, Syntaxin18, mUSE1 and mSec20 as the three Q-
SNAREs. The localization and the interaction between SNARE proteins forming the putative 
retrograde Golgi-to-ER complex were analysed using fluorescence techniques (FRET 
measurements by spectrofluorimetry and microscopy, bimolecular fluorescence 
complementation experiments) in living cells, as well as by co-immunoprecipitation.  
To study molecular mechanisms involved in retrograde Golgi-to-ER transport which 
could include the participation of SNARE-proteins, interaction of these SNAREs (except for 
Syntaxin18) with the KDEL-receptor was measured by FRET experiments. COPI vesicles 
were released from isolated Golgi apparatus in a cell-free assay and their protein contents 
were studied by Western-blotting and immuno-electron microscopy. Additionally, the isolated 
vesicles were used to perform co-immunoprecipitation experiments using mUse1 and 
mSec22b antibodies. The function of the different SNAREs was further studied using 
synthesized siRNA. In the case where the cell morphology was not affected by SNARE 
knock-down, the transport of cholera toxin was followed in transfected and WT cells in 
parallel.  
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3. MATERIALS 
 
3.1. Materials for culture 
 
3.1.1. Bacterial E. Coli strains 
 
Strain Relevant genotype/phenotype Source 
BL21 dcm, ompT, hsdS(rB-mB-), gal, F- Stratagene 
DH5α F-, supE44, ∆lacU169, (φ 80 lacZ, ∆M15), hsdR17, 
recA1, endA1, gyrA96, thi-1, relA1, ∆(lacZYA-
argF)U169 
Gibco-BRL 
XL1 Blue recA1, endA1, gyrA96, thi-, hsdR17, (rk-, mk+), 
supE44, relA1, lac-, [F', traD36, proAB, 
lacIqZ∆M15, Tn10 (tetr)] 
Stratagene 
 
For a description of gene nomenclature see Bachmann et al. [245]. 
 
3.1.2. Bacterial growth media 
3.1.2.1. Bacterial media 
All cultures were grown on liquid YT or LB media or solid LB medium. Compositions 
(for 1L) were as noted below.  
 
LB (Luria Bertani) media 10 g Bactotryptone and 5 g Yeast extract (Carl Roth), 5 g 
NaCl, ad 1 liter with distilled water 
12 g agar for solid media 
 
Low salt LB media 10 g Bactotryptone, 5 g Yeast extract, 2.5 g NaCl, ad 1 liter 
with distilled water 
12 g agar (BD Biosciences) for solid media 
 
2X YT 16 g Trypton, 5 g NaCl, 10 g Yeast Extract, ad 1 liter with 
distilled water 
2xYT is richer than LB and therefore allows for higher bacterial densities 
All media were autoclaved before use. 
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 3.1.2.2. Additives for bacterial culture 
LB-Kan, LB-Zeocin and LB-Amp media were prepared by adding kanamycin (ICM 
Biomedicals), zeocin (Invitrogen) and ampicillin (Sigma) respectively, from stock solutions 
of 100 mg/ml H2O (filtered) to the autoclaved media after the temperature of the media had 
fallen below 50°C. The working concentration of zeocin was 25 µg/ml, 50 µg/ml for 
kanamycin and 100 µg/ml for ampicillin. 
IPTG (Isopropyl-1-thio-β-D-galactopyranoside) was used for induction of protein 
synthesis at 0.2-1.0 mM final concentrations for liquid cultures, from 1 M filtered stocks. 
Tetracycline was prepared as a 1000x stock solution in 50% (v/v) ethanol and used at 12.5 
µg/ml. 
 
3.1.3. Mammalian tissue culture cell lines 
 
VERO cells are African green monkey kidney cells and were provided by ECACC 
(84113001). 
 
3.1.4. Mammalian cell medium and additives 
 
DMEM (Dulbecco´s Modified Eagle´s Medium) from Cambrex (Biowhittaker)      
with 4,5 g/L Glucose, sterile filtered 
Trypsin-EDTA (1X) from Cambrex 
0.5 gram per Liter Trypsin 1:250, 0.2 gram per Liter Versene (EDTA), 
sterile, pH : 7.1-7.9 
FCS (Foetal calf serum) for complementation of growth media was purchased from PAA.  
L-Glutamine in powder from Cambrex      
pH: 5.58-6.78, osmolality : 423-499 mOsm/kg 
MEM Na pyruvate from Gibco/BRL 
Penicillin-Streptomycin Mixture from Cambrex 
pH: 3.61-7.29, osmolality : 287-307 mOsm/kg 
Oligofectamin from Invitrogen and Opti-MEM1 from Gibco/BRL were used for si RNA 
transfection.  
HAM´s F-12 from PromoCell was used for its low fluorescence properties for imaging.  
 
Falcon provided all culture dishes used and coverlips were from Menzel-Gläser. 
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All chemicals used were of analytical grade and were purchased from Boehringer, Merck, 
Sigma or Serva, unless otherwise stated.  
 
3.2. Proteins, kits, enzymes and substrates 
 
Secondary antibodies (anti-mouse or anti-rabbit) coupled to indigocarbocyanine dyes 
(Cy3 and Cy5) were purchased from Jackson ImmunoResearch Laboratories. Secondary 
antibodies (anti-mouse or anti-rabbit) coupled to HRP (HorseRadish Peroxidase) were from 
Dianova. 
Monoclonal antibodies against rBet1 were kindly provided by Dr. Jesse Hay (University 
of Michigan, Ann Arbor, Mich.), monoclonal antibodies against syntaxin 18 (human) were a 
kind gift of Prof. Mitsuo Tagaya (School of Life Sciences, Tokyo), polyclonal rabbit 
antibodies against β´-COP were generously provided by Dr. Britta Brügger (Biochemistry 
Center, University of Heidelberg) and monoclonal antibodies against ERGIC53 were kindly 
given by Dr. Hans-Peter Hauri (Biozentrum, University of Basel). 
Plasmid DNA extraction from E. coli, DNA extraction from agarose gels and purification 
of PCR products were performed with Qiagen Spin Miniprep or Maxiprep Kits, QIAquick 
Gel Extraction Kit, PCR Purification Kit and a Nucleotide Removal Kit respectively, from 
Qiagen.  
For chemiluminescence, the Western LightningTMChemiluminescence Reagent Plus kit 
from Perkin Elmer was used. 
Restriction enzymes were from Fermentas or New England Biolabs. Taq-polymerase, T4-
DNA ligase and Pfu-Polymerase were from PAN Biotech, Fermentas and Promega, 
respectively.  
1kb-DNA and Standard-protein MW (Molecular Weight) markers were purchased by 
Fermentas and Peqlab, respectively. 
 
3.3 Filter materials and chromatography media 
 
Pharmacia's P10 and P20 columns were used for rebuffering of protein and for separating 
the labeled CTX or antibodies from the fluorescent dye after labeling. Filter paper and 
nitrocellulose membranes for Western blotting were supplied by Schleicher und Schüll and 
Sartorius. 
All FPLC chromatography media (MonoQ) as well as Q Sepharose FF, and Protein A 
Sepharose media came from Amersham Pharmacia Biotech. GSH-agarose and CNBr-
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activated agarose were also provided by Amersham Pharmacia Biotech, and Ni2+-
nitrilatriacetic acid-agarose (Ni-NTA) was from Qiagen.  
 
3.4. cDNA 
 
Cloning of mouse Sec20 was performed by Prof. HD. Söling in the laboratory, Rat Use1 
was cloned by Dr. Gabriele Fisher von Mollard (Biochemistry II, University of Göttingen), 
mouse Sec22b was a kind gift from Dr. Jesse Hay (University of Michigan, Ann Arbor, 
Mich.) and human Syntaxin18 was a kind gift from Prof. Mitsuo Tagaya (School of Life 
Sciences, Tokyo, Japan).  
 
3.5. Plasmid vectors 
 
For protein expression in bacteria, the vectors pGEX-4T3 and pGEX-6P-2 were obtained 
from Amersham Pharmacia Biotech.  
For in vitro transcription/translation, the pCMV TNT vector was purchased from 
Promega. 
Plasmids coding for GFP variants ECFP, EYFP, EGFP (N1 or C1) were purchased from 
Clontech (Heidelberg, Germany). 
The vectors pC1- and pN3-GFP2 were from Biosignal Packard and Perkin Elmer 
respectively.  
The plasmid coding for NPY-venusYFP was a kind gift from Dr. Atsushi Miyawaki 
(RIKEN institute, Hirosawa, Japan) (Nagai T. et al., Nat Biotech 2002) and was used to 
construct the vectors pN1-venusYFP and pC1-venusYFP. 
 
3.6. siRNA and primers 
 
siRNA duplexes against human Sec22b (5′-CCAGAAGGUGAUGUACGGCdTdT-3′ 
sense and 3′-dTdTGGUCUUCCACUACAUGCCG-5′antisense) and human Sec20 (5′-
CCAGAAGGUGAUGUACGGCdTdT-3′ sense and 3′-dTdTGGUCUUCCACUACAUGCC 
G-5′ antisense) were produced by MWG. Stealth siRNA against human USE1 (5′-
UCAUCUUCAUUAGCA UGAUCCUCUU-3′ sense and 3′-AAGAGGAUCAUGCUAAUG 
AAGAUGA-5′ antisense) were produced by Invitrogen. siRNA oligos against lamin (5′-
CUGGACUUCCAGAAGAACAdTdT-3′ sense and 3′-dTdTGACCUGAAGGUCUUCUUG 
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U-5′ antisense) and GL2 (5′-CGUACGCGGAAUACUUCGAdTdT-3′ sense and 3′-dTdTG 
CAUGCGCCUUAUGAAGCU-5′ antisense) were produced by Dharmacon Research. 
Primers for PCR reaction were produced by either MWG or Invitrogen.  
 
3.7. Buffers and solutions 
 
PBS (phosphate buffered saline):  137 mM NaCl 
2.7 mM KCl 
8.1 mM Na2HPO4
1.4 mM KH2PO4 ; pH 7.4 
 
Buffers for specific purposes are to be found in the relevant section, of the Methods chapter. 
 
3.8. Material for fluorescence microscopy 
 
The microscope used for imaging was an Axiovert 200 inverted microscope from Zeiss 
equipped with an oil-immersion 100× 1.4 NA Plan Apochromate objective lens. A CCD 
camera provided by Kodak, Princeton Instruments was connected to this microscope and used 
for imaging. The whole system was monitored by the program Metamorph 6.0 (Universal 
Imaging Corp.). 
All filter sets came from AHF Analysentechnik. 
The pictures were analysed with the program Imspector kindly provided by Dr. Andreas 
Schönle (Department of Nanobiophotonics, Max-Planck Institute for Biophysical Chemistry), 
unless otherwise stated. 
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4. METHODS 
 
4.1. cDNA cloning and construction of expression vectors 
 
4.1.1. cDNA constructs 
4.1.1.1. Constructs for expression of fluorescent fusion proteins in mammalian cells 
mSec22b and mUse1 were subcloned into the different GFP-C1 vectors coding for the 
GFP variants (including the BIFC vectors) using the restriction enzymes EcoRI and BamHI. 
For mSec20 subcloning, EcoRI and SalI were used. Syntaxin18 was subcloned into the vector 
pC1-YFP using the restriction enzymes BglII and EcoRI. 
For Erd2, the restriction enzymes Pst1 and SacI were used for cloning into pN3-GFP2. For 
cloning the sequence encoding Erd2 into the N1 vectors coding for ECFP, EYFP and vYFP, 
Eco47III and AgeI restriction enzymes were used. 
Starting from the pNPY-N1-venusYFP plasmid (NPY = Neuropeptide Y) and the primer 
pair 5´-TAATTAACCGGTCGCCACCATGGTGAGCAAGGGCGA-3´ (forward) and 5´-
TATAATAGATCTCTTGTACAGCTCGTCCATGCCGAG-3´ (reverse), the sequence 
encoding venusYFP was amplified and ligated into the AgeI/BglII restriction enzyme sites of 
the expression vector pC1-EGFP previously digested with the same enzymes.  
 
4.1.1.2. Constructs for protein expression in bacteria 
Starting from the pEGFP-Sec22 plasmid, the sequence encoding Sec22(∆TM) was 
amplified and ligated into the BamHI/NotI restriction enzyme sites of the expression vector 
pGEX-4T-3. This placed the Sec22 sequence in frame with the upstream GST sequence, 
allowing for purification of expressed fusion protein over glutathione-agarose columns. In the 
expressed protein, a thrombin cleavage site between GST and the Sec22 sequence was 
available.  
The sequence encoding Use1(∆TM) was generated by PCR. This fragment, flanked by 
restriction sites for NdeI and XhoI, was cloned into pET28 via the NdeI/XhoI sites and 
transformed into E. coli XL1-Blue. This placed the coding sequence for Use1 in frame with, 
and 3' of, the hexahistidine encoding sequence of pET28. The purification of the His6-tagged 
protein was performed over a Ni-beads column. 
Starting from the pEGFP-Syntaxin18 plasmid, the sequence encoding Syntaxin18 (∆TM) 
was amplified by PCR and ligated into the BamHI/NotI restriction enzyme sites of the 
expression vector pQE30. This placed the Syntaxin18 sequence in frame with the sequence 
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encoding a hexahistidine tag immediately upstream, allowing for purification of expressed 
fusion protein over Ni-beads columns.  
 
4.1.1.3.Construct pCMV-TNT-Sec20 for in vitro transcripton/translation  
Starting from the pEYFP-Sec20 plasmid, the primer pair 5'-CTGAATGAATTCG 
GACCATGGATGGCGGCTCCCCAGGATGTC-3' and 5'-AAGAGGGTCGACTTA 
CAAAAATGGAAAGAGGCG-3' was designed to insert the kozak sequence ACCATGG 
upstream of the sequence encoding Sec20 which was amplified and ligated into the 
EcoRI/SalI restriction enzyme sites of the expression vector pCMV-TNT.  
 
Escherichia coli strain XL1-Blue was used to amplify plasmid DNA. Sequencing of DNA 
was performed by Seqlab, the files were read with the program DNA-Star and sequences 
verified with the internet program http://probes.toulouse.inra.fr/multalin/ multalin.htlm/. 
 
4.1.2. PCR amplification of DNA 
  
The typical reaction mixture for PCR is composed of 50-100 pmol forward and reverse 
primers in dH2O, 1x nucleotide mix (200 µM dATP, dCTP, dGTP, dTTP), 1x PCR buffer 
with MgCl2 (20 mM Tris/HCl, pH 8.4; 50 mM KCl; 2.5 mM MgCl2), ~20 ng template DNA 
in dH2O or 10 mM Tris/HCl, pH 8.5, 1 U DNA polymerase and double-distilled H2O was 
added to 50 µl final reaction volume. 
The primers may have modifications such as extensions at their 5' ends or deletions, insertions 
and point mutations allowing for specific changes to the amplified sequence. 
 
On a MJ Research Inc. model PTC 150-25 MiniCycler (Biozyme), typical reaction conditions 
for a primer with modifications that are not present in the initial template are: 
Step T (°C) time (s) description 
1 95 5 denaturation 
2 85 hold hot start: addition of DNA 
polymerase 
3 94 50 denaturation 
4 T1 25 partial primer annealing 
5 72 t extension 
6 -- -- cycle 5 times  to  step 3 
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7 94 50 denaturation 
8 T2 25 Full primer annealing, T2> T1
9 72 t extension 
10 -- -- cycle 25 times to step 7 
11 4 hold end of reaction 
 
The annealing temperature (T) is determined for each primer pair separately and is dependent 
on the degree of homology between each primer and its template and the content of high-
melting, paired G and C bases. An estimate is given by the following empirical relationship 
[246]: T (°C) = 69.3 + 0.41 x (GC%) - 650/l where l = (overlap length in bases) 
The lower of the two temperature values for a primer pair is used in the reaction. The 
extension time (t) is dependent on the length of the target sequence and the DNA polymerase 
used. For Taq DNA polymerase, a rate of 1000 bases per minute was used in computations. 
 
4.1.3. DNA gel electrophoresis 
 
At neutral pH, the negatively charged DNA molecules migrate under the influence of an 
electrical field from the cathode to the anode. The distance migrated is dependent on fragment 
size and fairly independent of base or sequence composition. The bands are made visible 
under ultraviolet light of 302 nm by incubating the gel in a solution of ethidium bromide (0.5 
µg/ml), which binds to the DNA. 
Gels were prepared according to the size of the DNA fragments of interest as follows: 
  Agarose concentration (%)   Resolving size range (kb) 
   0.5      1.0-30 
   0.7      0.8-12 
   1.0      0.5-10 
   1.2      0.4-7.0 
   1.5      0.2-3.0 
   2.0      0.05-2.0 
 
Agarose gel material was added to an appropriate volume of 1 X TBE and boiled in a 
microwave oven until all the agarose had dissolved (~ 5 min). The liquid gel was then poured 
into a horizontal chamber. Two of its sides were sealed with a 2.5 cm wide Drapore® and the 
comb was placed into the chamber for slot formation. The comb was removed after agarose 
gel polymerisation. The gel was then immersed into an electrophoresis chamber filled with 1 
  39 
 Methods 
___________________________________________________________________________ 
X TBE buffer. The samples were then mixed with gel-loading buffer (stock solution 6 fold) 
and finally loaded into the slots. The applied current was 85 mA. 
 
10X TBE :   500 mM Tris; 500 mM H3BO3; 10 mM EDTA 
6X gel-loading solution : 20% (v/v) Ficoll; 0.125% (w/v) bromophenol blue; 
    0.125% (w/v) Xylene-cyanol in H2O 
Ethidium bromide :  10 mg/ml in H2O 
 
PCR products, DNA inserts and plasmids were run on a suitable agarose gel. When 
necessary, the desired bands were excised from the gel with a scalpel and DNA was isolated 
using a QIAGEN gel extraction kit according to the manufacturers recommendations. The 
principle of the QIAGEN kit consists in DNA binding to a solid support (a silica-gel 
membrane) in the presence of chaotropic salts and low pH (pH<7.5) and elution after removal 
of salt with a buffer of pH>7.5, such as TE-buffer. 
 
4.1.4. Estimation of DNA purity and quantitation 
 
4.1.4.1. Spectrophotometric Determination  
For the quantification of the amount of DNA, readings were taken at 260 nm and 280 nm 
using a GeneQuant II spectrophotometer (Pharmacia). The reading at 260 nm allows the 
calculation of  the concentration of nucleic acid in the sample. An OD of 1 corresponds to 
approximately 50 µg/ml dsDNA, 40 µg/ml ssDNA and 31 µg/ml oligonucleotide DNA. The 
ratio OD260/OD280 provides an estimate of the purity of the nucleic acid. Pure preparations of 
DNA have ratio values of 1.8. If there is contamination with protein or phenol, the ratio will 
be significantly less than 1.8. 
 
4.1.4.2. Ethidium bromide fluorescent quantification  
In case of a low concentration (<250ng/ml) or heavy contamination of the DNA solution, 
the concentration can be determinated by measuring the ultraviolet-induced fluorescence 
emitted by ethidium bromide molecules intercalated into the DNA by an using UV light table. 
Because the amount of fluorescence is proportional to the total mass of DNA, the quantity of 
DNA (as little as 1 to 5 ng can be detected) in the sample can be estimated by comparing the 
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fluorescence yield of the sample with that of a series of standards in 1 µl of a 1 kb ladder 
solution (0.5mg/ml). 
  
4.1.5. Competent E.coli 
 
4.1.5.1. Preparation and transformation by heat shock 
The method of Inoue et al. [247] was employed. A fresh 250 ml culture, inoculated 
with cells of the desired strain from an overnight culture, was harvested by centrifugation (10 
min at 4,000 x gav, 4°C) upon reaching an A600 of 0.5-0.9. The cells were cooled on ice for 30 
min and then washed twice with ice cold water. After resuspension in 25 ml sterile filtered 
TB, the cells were centrifuged again at 7,000 x gav for 5 min, 4°C, and resuspended once more 
in 5 ml TB. 300 µl aliquots were taken and stored at -80°C in the presence of 7% (v/v) DMSO 
unless used immediately. 
 
TB (Transformation buffer) : 10mM PIPES, pH 6.7; 55 mM MnCl2;  
15 mM CaCl2; 250 mM KCl 
     (pH is set before addition of MnCl2) 
 
200 µl of competent E. coli cells were thawed on ice and added to 10-50-ng of plasmid 
mixture. Cells were incubated for 30 min on ice, then heat shocked for 1.5 min at 42°C in a 
water-bath. Thereafter, 1 ml LB was added and the samples were incubated at 37°C for 45 
min to allow initiation of the expression of selection marker proteins. Finally, 20 µl and 100 
µl respectively were plated on agar plates containing the appropriate antibiotic of selection 
and incubated overnight at 37°C. 
4.1.5.2. Preparation and transformation by electroporation 
A 10 ml overnight culture of E. coli XL1-Blue cells in LB-tetracyclin was used to 
inoculate 1 L of fresh LB medium. The culture was grown at 37°C with agitation for about 
2.5 h until an A600 of 0.5-0.7 was achieved. The flask was cooled on ice for about 30 min, and 
the cells were thereafter collected by centrifugation at 4,000 x gav for 20 min at 4°C. The cells 
were resuspended in 1 L of ice cold, sterile HEPES buffer, spun again as above, resuspended 
a second time in 500 ml HEPES buffer, spun, resuspended a third time in 20 ml HEPES 
buffer with 10% (v/v) glycerol, centrifuged again and finally resuspended in 2-3 ml sterile 
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10% (v/v) glycerol. The cells where then dispensed in 50-100 µl aliquots and frozen on dry 
ice. The frozen cells were stored at -80°C. 
 
HEPES buffer: 1 mM HEPES, pH 7.0 
10% glycerol: 10% (v/v) glycerol in distilled water         
HEPES/glycerol: 1 mM HEPES, pH 7.0; 10% (v/v) glycerol 
All solutions were sterilised by autoclaving before use. 
 
For transformation, 50 µl electro-competent E. coli XL1-Blue cells were thawed on ice 
and transferred to a chilled 0.2 cm electroporation cuvette (Bio-Rad). 1 to 5 µl salt-free 
plasmid DNA was added and the sample kept on ice for 1 min. Thereafter, the cuvette was 
transferred to a Gene Pulser electroporation chamber (Bio-Rad) and pulsed with 25 µF, 2.5 
kV, 200 ohms. The time constant was usually about 4.5-5 ms. 1 ml LB medium was added 
immediately after pulse and the sample transferred to a 1.5 ml Eppendorf tube and incubated 
with agitation at 37°C for 1 h. 10-100 µl of the sample was then plated onto LB-Amp, LB-
Kan or LB-Zeocin plates and incubated overnight at 37°C. 
 
4.1.6. DNA preparation  
 
Small- and large-scale plasmid extractions were performed using Plasmid mini- and maxi-
prep kits from Qiagen according to the manufacturers recommendations. The basic principle 
involves alkaline lysis of the cell wall, degradation of RNA by RNase, precipitation of 
proteins and chromosomal DNA with high salt and binding of plasmid DNA to a silica-gel 
matrix.  
 
4.2. Expression and purification of recombinant proteins 
 
4.2.1. Expression and purification of GST-Sec22b and GST 
 
One L LB containing ampicillin was inoculated with 10 ml of an overnight culture of E. 
coli BL21 harbouring the vector construct pGEX-mSec22b(∆TM) or the vector pGEX-6P and 
the cells were cultured at 37°C till an A600 of 0.6-0.9. IPTG was added to 0.5 mM to induce 
protein expression. After 3 hours, the cells were harvested by centrifugation at 2,500 x gav for 
30 min at 4°C. The pellet was resuspended in the following buffer: PBS, pH 7.4; lysozyme 1 
mg/ml; DNase 10µg/ml; 5 mM MgCl2 and protease inhibitor (Complete protease inhibitors 
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cocktail, 1 tablet, Roche) at 40 ml/liter of culture and incubated for 30 min on ice. Thereafter, 
the cells were disrupted by sonicating in 10 bursts of 30 s at 50% of output and 8 duty cycles 
using a Branson model 450 Sonifier. This was repeated 5 times. 
Triton X-100 was added to 1% (v/v) and the lysate was rotated for 20 min at 4°C. The 
sample was spun at 30,000 x gav for 30 min at 4°C. The pellet was discarded and the 
supernatant spun at 180,000 x gav for 30 min at 4°C. The supernatant was bound to 3 ml 
settled Glutathione-Sepharose, prewashed with PBS, for 30 min at 4°C with end-over-end 
rotation. After this batch-binding procedure, the sample was transferred to a 10 ml Mo Bi Tec 
gravity-flow column and washed five times with 10 ml each of PBS. Elution was performed 
using 10 ml Elution buffer and collecting 1 ml fractions. The eluates, containing eluted GST-
mSec22b, were pooled, aliquoted and stored at – 80°C. 
 
Elution buffer : 50 mM Tris/HCl, pH 8.0; 10 mM reduced glutathione (GSH) 
 
4.2.2. Expression and purification of His6-mUse1 
 
A colony from a plate with freshly transformed E. coli BL21(DE3) cells harbouring 
the vector pET28-mUSE1(∆TM) was used to inoculate 25 ml of 2xYT medium containing 
kanamycin. The overnight culture grown at 37°C was then added to 500 ml of fresh 2xYT 
containing kanamycin and the cells were grown until an A600 of 0.6-0.9 was reached. 
Expression of recombinant proteins was then induced by the addition of IPTG to 0.2mM. 
After a 4 h induction period at 30°C, the cells were centrifuged for 15 min at 3,000 x gav at 4 
oC and then resuspended in 20 ml of binding buffer. Protease inhibitors (tablet Complete 
Roche) were added directly before French Press lysis which was performed cracking twice 
with 1200 psi. The sample was spun at 4°C 10 min at 17,000 x gav to remove insoluble 
material. The supernatant was centrifuged a second time. 1 ml of washed (with Washing 
buffer) Ni-NTA beads was added to the supernatant. His-tagged proteins were allowed to bind 
for 1h at 4°C with end-over-end rotation and the solution transferred into a 10 ml Mo Bi Tec 
gravity-flow column. The beads were washed with 10 ml of washing buffer. Elution was 
performed using 2 ml of washing buffer containing imidazol, pH 6,0 and collecting 1 ml 
fractions. This was done four times, each time increasing the amount of imidazol (50mM, 
100mM, 250mM and 500mM). Each eluate fraction was then analyzed for purity and yield on 
SDS-gel. The purified His-Use1 was aliquoted and stored at -80°C. 
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Binding buffer: 50 mM NaPO4, pH 8,0; 300 mM NaCl  
Washing buffer: 50 mM NaPO4, pH 6,0; 300 mM NaCl 
 
4.2.3. Expression and purification of His6-Syntaxin18 
 
XL1-Blue bacteria were transformed with pQE30-Syn18∆TM. Bacteria (1 clone) were 
grown in 50 ml LB-Amp at 37°C. The overnight culture was added to 500 mL LB-Amp and 
bacteria were grown at 37°C to an A600 of 0.8. Protein production was induced with 0.25 mM 
IPTG for 3h at 30°C. The cells were harvested by centrifugation at 2,500 x gav for 30 min at 
4°C, and the pellet was resuspended in 25 ml of the following buffer: PBS, pH 7,4, containing 
Pefabloc 0.5 mg/ml, lysozyme 1 mg/ml, DNase 10 µg/ml, MgCl2 5mM and protease 
inhibitors with EDTA. The suspension was incubated for 30 min on ice and sonicated as 
described previously for GST-mSec22b(∆TM). TritonX-100 was added to 1% (v/v) and the 
suspension incubated for 30 min on ice. The sample was spun at 40,000 x gav for 45 min at 
4°C. The pellet was resuspended in 15 ml PBS containing 8M urea, 0.1% Triton X-100 + 0.5 
mg/ml Pefabloc and spun again at 40,000 x gav for 45 min at 4°C. The supernatant was then 
added to PBS washed nickel beads and rotated for 30 min at 4°C. The sample was spun at 144 
x gav for 5 min at 4°C and then the resin was transferred to a column and washed until no 
more proteins appeared in the flow-through. The bound protein was eluted with elution buffer 
and 1 ml fractions were collected.  
The eluates obtained for His-Syn18 were loaded onto an FPLC MonoQ 10/10HR 
column. MonoQ is a strong anion exchanger with trimethyl-aminomethyl (-CH2N+(CH3)3) 
moieties as functional groups. The proteins were then eluted with a standard linear gradient 
with buffer 1 and 2. Protein peaks were identified by SDS-PAGE.  
 
Elution Buffer: 50 mM Tris-HCl, pH 8,0; 8 M Urea 
Buffer 1: 20 mM Tris, pH 7.4 
Buffer 2: 20 mM Tris, pH 7.4; 1 M NaCl  
   
4.3. Protein quantitation 
 
The determination of the protein concentration was carried out according to Bradford 
(1976) [248] by measuring the extinction (E) of 1 µl protein solution in 1 ml of staining 
solution at 595 nm in a spectrophotometer against a control containing 1 µl of water in 1 ml 
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staining solution. Determination of the protein concentration was based on the concentration 
curve of bovine serum albumin (1 µg to 10 µg) from which the factor of the staining solution 
was derived. The factor is the ratio of the weight of bovine serum albumin and the extinction 
in the linear region of the standard curve.  
Protein concentration (µg/ µl) = (∆E x Factor x Dilution) / (Volume of protein solution) 
The factor of the staining solution was in the range of 15 to 20 µg/unit of extinction. 
 
Staining solution:  100 mg Coomassie brilliant blue G 250 
    50 ml 95% (v/v) ethanol, 100 ml 85% (v/v) phosphoric acid 
    ddH2O to 1 liter, filter the solution 
 
4.4. Denaturing polyacrylamide gel electrophoresis (SDS-PAGE) 
 
The principle of polyacrylamide gel electrophoresis is separation of a large range of 
proteins of varying molecular weights under the influence of an electrical field by a 
continuous, cross-linked polymer matrix. Here, the polymer is polyacrylamide and the cross-
linking agent bis-acrylamide. Cross-linking is effected through a radical-induced pathway 
[249] by the addition of ammonium peroxide sulfate (APS) and TEMED (1,2-Bis-
(dimethylamino)-ethane).  
Two gels are employed: a stacking gel with a low level of cross-linkage and low pH, 
allowing protein bands to enter the gel and collect without smearing, and a separating gel with 
a higher pH, in which the proteins are separated on the basis of size. The proteins migrate 
under the influence of an applied electrical field from the cathode to the anode.  
The detergent sodium dodecyl sulphate (SDS) is known to bind to proteins at an average 
of one SDS molecule per two amino acid residues, or roughly 1.4g per g protein, when 
present at concentrations above 0.8mM. SDS is employed to effect denaturation of the 
proteins, to dissociate protein complexes and to impart upon the polypeptide chains net 
negative charge densities proportional to the length of the molecule. A reducing agent such as 
dithiothreitol (DTT) or 2-ME is used to reduce any existing cystines (disulphide bonds).  
The electrophoretic mobility of such SDS-protein complexes is inversely proportional to the 
logarithm of the molecular mass of the protein [250]. For 8x6x0.1 cm gel, the following 
volumes were used:    
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 Stacking gel  Separating gel 
         5 %  10%  12.5%  15%  
Separating buffer       --   1.5 ml  1.5 ml  1.5ml 
Stacking buffer       625 µl   --   --   -- 
Acrylamide        375 µl  2.0 ml  2.5 ml  3.0 ml  
dH2O         1.25 ml  2.5 ml  2.0 ml  1.5 ml 
TEMED        3 µl  3 µl  3 µl  3 µl 
APS         60 µl  60 µl  60 µl  60 µl 
 
5 X sample buffer: 312.5 mM Tris/HCl, pH 6.8;10% (w/v) SDS; 
    50% (v/v) Glycerol; 1.25% (v/v) 2-Mercaptoethanol; 
    0.3% (w/v) Bromophenol blue 
 
Acrylamide/Bis: 29.2% (w/v) Acrylamide; 
    0.8% (w/v) Bis(N,N’-bis-methylene-acrylamide) 
Stacking buffer: 0.5 M Tris/HCl, pH 6.8 
Separating buffer: 0.5 M Tris/HCl, pH 8.9 
Running buffer: 25 mM Tris; 192 mM glycine; 0.1% (w/v) SDS 
SDS:   10% (w/v) 
APS:   10% (w/v) 
 
Protein separation was carried out by discontinuous gel electrophoresis according to 
Laemmli [251]. The gel solution was poured between two glass plates separated by a 0.1 cm 
spacer and overlayed with 200 µl isopropanol to straighten the surface of the gel. After 
polymerisation the alcohol was removed with water. When stacking gel was poured 
appropriate comb were introduced to form wells for sample loading. The samples were 
diluted with sample buffer and heated for 2 min at 95°C and loaded onto the gel. Molecular 
weight standards were used for size comparison. Separation was carried out at 20-25 mA 
constant current for 1 gel. 
Staining of the gels was carried out for 2 hours at RT by immersing the gels into staining 
solution with mild shaking. Destaining was done by immersing the gel first into destaining 
solution I and then into destaining solution II until the background was completely removed. 
The gel was then soaked in water for at least three hours and sandwiched between polyester 
sheets and dried in a gel dryer for further documentation and autoradiography. 
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Staining solution :  0.2% (w/v) Coomassie brilliant blue R250; 
    50% (v/v) methanol; 10% (v/v) acetic acid; 
    40% (v/v) ddH2O 
Destaining solution I :  50% (v/v) methanol; 10% (v/v) acetic acid 
    40% (v/v) ddH2O 
Destaining solution II : 10% (v/v) methanol; 5% (v/v) acetic acid 
    85% (v/v) ddH2O 
 
4.5. Generation of antibodies  
 
4.5.1. Production and purification 
 
For the preparation of polyclonal antibodies against mSec22 and mUSE1, GST-
mSec22b(∆TM) and His6-Use1(∆TM) proteins (300µg) emulsified in complete Freund´s 
adjuvant were injected subcutaneously into two rabbits each. The polyclonal antibodies 
against mSec20 were raised against a HPLC purified synthetic peptide corresponding to the N 
terminal part of mSec20 with an additional N-terminal cysteine (mouse, C-MAAP 
QDVHVRICNQE, generously synthesised by Kerstin Overkamp, Dept. of NMR II, Max-
Planck Institute for Biophysical Chemistry, Göttingen). Booster injections were performed 
every 2 to 3 weeks for 3 to 4 months. Serum was extracted from ear veins 10 days after the 
second and subsequent booster injections.  
Polyclonal antibodies directed against ERD2 were raised in rabbits using synthetic 
peptides as described previously[252].  
Antibodies against the A-subunit of cholera toxin were raised in rabbits. Traces of 
antibodies against the B-subunit were removed by passing the antiserum over a column with 
immobilized cholera toxin B. These antibodies were then labelled with the monofunctional 
reactive fluorescent dye Cy5 (Amersham Pharmacia Biotech) according to the manufacturer’s 
recommendations.  
4.5.1.1. IgG purification using protein A Sepharose 
IgG fractions from serum were purified over Protein A-Sepharose columns as follows: 
1 ml of serum was spun for 30 min at 14 000 g in a tabletop centrifuge. The pH of the 
supernatant was set to 8.1 with 1 M Tris/HCl pH 9, and the sample was then applied to a 
column holding 1 ml of Protein A-Sepharose pre-washed with 10 ml Pi buffer. Binding of 
IgG proteins was allowed to proceed overnight by slowly (~0.25 ml/min) circulating the 
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serum repeatedly over the column with the aid of a peristaltic pump. The column was then 
washed with buffer Pi until all unbound proteins had been washed out (measured at A280).  
Bound IgG was eluted in one step with Elution buffer. Eluted proteins were collected in 1.5 
ml tubes already containing sufficient neutralisation buffer (~300 µl) for immediate 
neutralisation. 
 
Pi buffer: 0.1M sodium phosphate, pH 8.0; 0.01% NaN3 
Neutralisation buffer: 1M Tris/HCl, pH 9.0 
Elution buffer: 0.2M glycine, pH 3.5 
 
The fractions were further aliquoted and frozen or used for further purification as 
described below. 
4.5.1.2. Purification of antibodies over antigen-bound Sepharose 
CNBr-activated Sepharose is supplied freeze-dried (1g was suspended in 5ml of 1mM 
HCl) in the presence of additives. These additives were washed away at low pH with an 
excess of 1 mM HCl (pH 2-3) before coupling the desired ligand. The use of low pH 
preserves the activity of the reactive groups, which otherwise hydrolyze at high pH. 
The solutions containing the proper antigen were dialyzed against coupling buffer and 
coupled to CNBr-activated Sepharose (2 to 3 mg of antigen were coupled per ml gel), rotating 
1 hour at room temperature. The excess of ligand was washed away with at least 5 gel 
volumes of coupling buffer. Remaining binding sites were blocked and the resin was then 
washed with washing buffer 1 followed by a wash with buffer 2, this cycle was repeated 3 
times. Antiserum (3 to 4 ml) was incubated overnight at 4°C rotating with the resin (1 ml). 
The mixture was transferred to a suitable column (5ml Mo Bi Tec column, Mo Bi Tec). This 
column was washed with PBS until the A280 dropped to zero. The specific antibodies were 
eluted with elution buffer and collected fractions (1 ml) were immediatly neutralized with 
50µl of neutralisation buffer. BSA (about 1mg/ml) was added for stabilization. The antibodies 
were aliquoted and stored at 4°C or at -80°C.  
The antibodies raised against GST-mSec22b(∆TM) were previously passed through a GST-
column to remove the antibodies raised against the tag. 
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Coupling buffer:  0.1M NaHCO3, pH 8.3; 0.5M NaCl 
Blocking:   0.2M glycine, pH 8.0 
Washing buffers:  1: 0.1M Na-acetate, pH 4.0; 0.5M NaCl 
   2: 0,1M Tris/HCl, pH 8.0; 0.5M NaCl 
Elution buffer:  0.1M glycine, pH 3.0 
Neutralisation buffer: 1M Tris/HCl, pH 9.0 
 
4.6. Western blotting 
 
4.6.1. Protein transfer onto nitrocellulose membranes 
 
A semi-dry set-up (Millipore Milli-Blot SDE-System) was employed. One piece of pre-cut 
Whatman filter paper was equilibrated in blot buffer and placed on the cathodic plate. The 
electrophoresed separating gel and then, the nitrocellulose membrane were equilibrated in blot 
buffer and added on top. Two more pieces of blot buffer-wetted Whatman filter were layered 
on top of this sandwich. Finally, this sandwich was positionned between two closely spaced 
solid phase electrodes with were in direct contact with the buffer-wetted Whatman filter 
paper. For an 8x6x0.1 cm gel, transfer was carried out at 100 mA constant current for 1 hour. 
To test the quality of transfer, the proteins on the  blot membrane were stained with Ponceau-
S and destained with PBS. 
 
Blot buffer :  25 mM Tris/HCl; pH 8.3 
   192 mM glycine 
   20% (v/v) methanol 
 
Ponceau S solution : 0.1% (w/v) Ponceau S; 5% acetic acid 
 
4.6.2. Immunoblot and detection 
 
After transfer of proteins, the nitrocellulose membrane was incubated under mild 
shaking in PBS containing 0.5%(w/v) dry milk for 2 hours at RT or overnight at 4°C. The 
membrane was then incubated with the first antibody diluted in PBS containing 0.5%(w/v) 
dry milk. It was washed twice each for 5 min with PBS, followed by incubation with the 
secondary antibody (conjugated to horseradish peroxidase) diluted 1:10000 in PBS containing 
0.5% (w/v) dry milk. It was then washed three times each for 10 min with PBS containing 
0.05% (w/v) Tween20 and finally incubated with Chemiluminescence substrate for exactly 2 
min. This substrate was prepared by mixing a peroxide solution as substrate for horseradish 
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peroxidase and a Luminol/enhancer solution for amplification of the signal according to the 
manufacter’s recommendation. The membrane was immediately wrapped with plastic sheet 
and the signal recorded on a Fujifilm LAS-100 cooled CCD instrument using Image Reader 
and Raytest Aida image analysis software (Fuji). 
 
4.7. Mammalian cell culture techniques 
 
4.7.2. Starting a culture from frozen cells 
 
Frozen cells were thawed in a waterbath (37°C) and transferred rapidly to a 15 ml 
centrifuge tube. Ten ml of the appropriate, pre-warmed medium was added; the tube was 
mixed gently, and then centrifuged at 200 x gav for 5 min. The supernatant was decanted, the 
cells resuspended in fresh medium and the tube centrifuged again as previously. The cell 
pellet was resuspended in a defined volume of medium including the recommended additives 
and then transferred to the appropriate culture vessel 
 
4.7.2. Cell culture 
 
VERO cells were cultured in Dulbecco's MEM, with 10% (v/v) heat inactivated FCS, 
with 2 mM glutamine, 100 U/ml penicillin, 0.1 mg/ml streptomycin and Na pyruvate, in 
humidified incubators with 10% CO2 at 37°C. For splitting, cells were washed twice in PBS, 
and then treated with trypsin/EDTA until they no longer adhered to the plate. They were split 
1:5 every 2 days or upon reaching confluency unless otherwise stated. 
 
4.7.3. Transfection of cultured VERO cells 
4.7.3.1. cDNA  
For DNA transfection, Vero cells were split 2 days before transfection, so that they 
reached 90% confluency on the day of transfection. Cells were then trypsinized, washed with 
PBS, and the pellet was resuspended in the DNA solution containing 1 to 3 different cDNAs 
of interest in 300µl transfection buffer. The suspensions were transferred to an electroporation 
cuvette and cells were immediately electroporated with a Gene Pulser II device (Bio-Rad, 
pulse 0.7 kV, 200 ohms, 50 µF, 1–2 ms). The cells were thereafter transferred to 6-well plates 
or culture dishes depending on the experiments to be performed and grown until the 
experiment. 
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For transfection of Vero cells, endotoxin-free plasmid DNA was prepared from E. coli strain 
XL1-Blue using the Endotoxin-free Plasmid Kit (Qiagen).  
 
Transfection buffer :  KCl 120mM, KH2PO4 10 mM, K2HPO4 10 mM, EGTA 2 mM,          
MgCl2 5 mM, HEPES  25 mM, CaCl2 0,15 mM,   
pH adjusted to 7,7 with KOH 
For complete cytomix, GSH  5 mM and ATP 2 mM (pH  7) were freshly added. 
 
4.7.3.2. si RNA 
For transfection, siRNA duplexes for lamin and GL2 were prepared as follows: sense 
and antisense oligonucleotides (20µM final concentration) were mixed with 2x annealing 
buffer, incubated for 1 min at 90°C, followed by incubation for 1h at 37°C. Solutions could be 
stored at -20°C. SiRNA lamin and siRNA GL2 were used as positive and negative controls 
respectively. SiRNA for Sec22b, Use1 and Sec20 were received as duplexes. 
Vero cells were plated on polylysin-coated coverslips in 24-well plates and cultured in a 
37°C incubator in DMEM supplemented with 10% FCS, L-glutamine and sodium pyruvate, 
but without antibiotics. After 12 hours, cells were transfected with siRNA duplexes according 
to Elbashir et al. [253]. For each coverslip, 3µl of Oligofectamine reagent were mixed with 
12µl of Opti-MEM and incubated for 7-10 min at RT. This solution was then gently mixed 
with 20 µM of siRNA duplex in 50µl of Opti-MEM 1 and incubated for another 20-25 min at 
RT. During this incubation, the cells on the coverslips were washed twice using DMEM 
containing only L-Glutamine and sodium pyruvate and left with 500µl of this medium. 32µl 
of fresh Opti-MEM were then added to the siRNA reagent tubes and 100µl of this final 
solution was added per well on the 24 well-plate. After 4 hours at 37°C, 500µl of DMEM 
containing 20% FCS, L-glutamine and sodium pyruvate were added to the cells. After 72 
hours, cells were either fixed for immunostaining or harvested for western-blotting.  
For final cell harvest, cells were washed twice with PBS, then trypsinised, spun and 
resuspended in 100µl homogenization buffer. Cells were then homogenized with syringes 
(passed through 20-, 23- and 27-gauge needles, 10 times each). Samples were spun 10 min at 
4°C at 100 x gmax and supernatant were loaded with SDS-sample buffer on SDS-gel. 
 
Homogenization buffer: HEPES 25mM, sucrose 0,25M, protease inhibitors. 
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4.8. Application of cholera toxin on cells 
 
 The cells were washed with PBS to remove the serum. The plates or the culture dish 
were placed on a thick metal plate that had been cooled to 0°C. The cells were then incubated 
for 20 min at 0°C with FCS-free DMEM containing 0.5 µg/ml of CTX to allow for binding of 
the toxin to the plasma membrane. Subsequently, the sample was warmed for 5 min to 37°C 
to start internalization of CTX. To remove as much free CTX as possible, the cells were 
rapidly washed three times with PBS. After the addition of DMEM with 10% FCS, the 
incubation was continued in an incubator (10% CO2) at 37°C. At the time points indicated, 
cells were fixed for immunostaining (as described chapter 4.9.) or used for FRET-
measurement (as described chapter 4.10.2).  
 
4.9. Immunostaining 
 
To study the cellular distribution of endogenous proteins, Vero cells grown on cover slips 
in 12- or 24-well plates to about 60% confluency, were washed twice with PBS and fixed 
with 4% paraformaldehylde for 12 min at 37°C. The fixed cells were then treated for 10 min 
at 37°C with 50 mM NH4Cl to block free aldehyde groups from the fixative, and then washed 
twice in PBS. Permeabilization was done with 0.1% saponin/PBS. Primary and secondary 
antibody incubations were performed for 1 h at 37°C in 0.1% saponin/PBS/3% BSA. For each 
SNARE-protein, rabbit antibodies were used at 1:10 dilution and detected with Cy3- or Cy5-
labeled goat anti-rabbit secondary antibodies (1:1000). When co-staining was performed Cy3-
labeled goat anti-rabbit and Cy5-labeled goat anti-mouse antibodies were used, recognizing 
rabbit anti-SNARE and mouse anti-specific markers respectively. After washing four times 
with PBS, the cover slips were mounted in DAKO Fluorescent Mounting Medium and viewed 
using the Axiovert 200 inverted microscope described in Materials. Cy3 fluorescence was 
visualized using the following filter set: a 565/30 nm excitation filter, a 595 nm dichroic filter 
and a 645/75 nm emission filter. For Cy5, the filter set was composed of an excitation filter 
620/60 nm, a dichroic filter 650 nm and an emission filter 700/75 nm. When no mouse 
antibody against the specific marker was available, this marker was expressed as GFP-fusion 
protein and anti-SNARE antibodies recognised with Cy5-labeled goat anti-rabbit antibodies. 
Colocalisation of 2 different labels was analysed using the program Imspector.  
When cells had been previously treated with CTX, the coverslips were removed and the 
cells fixed in 4% paraformaldehyde for 10 min on ice and for 20 min at room temperature to 
prevent toxin translocation during fixation. When first rabbit anti-SNARE and then Cy5-
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labeled rabbit anti-CTX were used for co-staining, one incubation step with normal rabbit 
serum was needed to block the free sites of the secondary anti-rabbit antibody used to 
recognize the anti-SNARE antibodies, before the anti-CTX antibody was applied. 
 
4.10. Protein-protein interaction assays 
 
4.10.1 Immunoprecipitation  
   
A crude membrane fraction was prepared from rat liver as follows: 5 livers of about 
15g each were cut into small pieces with a scapel, washed with ice-cold PBS and 
homogenized at 4ºC in a kitchen blender for 3 periods of 30 seconds each at maximum speed 
in 2 volumes homogenization buffer. Cell debris was removed by centrifugation at 3,000 x gav 
for 20 min at 4ºC, the pellet was discarded and the supernatant centrifuged again at 10,000 x 
gav for 20 min. Larger debris and floating fat were removed by filtering the supernatant, and 
the solvent was finally removed by centrifugation at 100,000 x gav for 90 min at 4ºC. The 
pellet was resuspended in 50 ml Microsome buffer and homogenized with a glass-Teflon 
Potter, centrifuged again at 100,000 x gav for 1 h. The resulting pellet was resuspended in 
about 20 ml Microsome buffer and homogenized, the protein concentration was brought to 
10mg/ml and the sample were stored in 1ml aliquots at -80ºC. 
 
Homogenization buffer : 280 mM sucrose; 50 mM Tris–HCl, pH 7.4; 1 mM EDTA; 
Complete protease inhibitors (1 tablet/100ml of buffer) 
Microsome buffer : 50 mM Tris–HCl, pH 7.4; 150 mM NaCl; 1 mM EDTA; 
 Complete protease inhibitors (1 tablet/100ml of buffer) 
 
For immunoprecipitation, the sample was solubilized in extraction buffer at a final protein 
concentration of 0.3 mg/ml, while rotating for 30 min at 4°C. Insoluble material was removed 
by centrifugation at 200,000 x gav for 60 min. Excess amounts of antibodies with the following 
specificities were then added to separate aliquots: mSec22b, mUse1, mSec20, rBet1 and 
syntaxin 18. After incubation overnight at 4°C, protein A–Sepharose was added in amounts 
sufficient to bind all IgG quantitatively, followed by incubation for 1 h at 4°C. Protein in the 
unbound material was precipitated according to Wessel and Flügge [254]. Bound material 
underwent six wash cycles of the protein A–Sepharose with extraction buffer followed by 
addition of SDS-sample buffer. Both bound and unbound proteins were analyzed by SDS–
PAGE and immunoblotting with the indicated antibodies.  
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Extraction buffer :  50 mM Tris–HCl, pH 7.4; 150mM NaCl; 1 mM EDTA; 
    0.1mM PMSF; 1% Triton X-100 
4.10.1.1.  Using in vitro synthesized [S35] methionine-labeled mSec20 
Cell-free systems for in vitro gene expression and protein synthesis have been 
described for many different eukarytic systems [255, 256]. The standard reaction conditions 
for in vitro transcription/translation using the kit  from Promega are as follows: 40 µl of TNT 
Quick Master Mix, 2 µl of  [35S]methionine (1,000 Ci/mmol at 10mCi/ml), 1µg of plasmid 
DNA template, and nuclease-free water to a final volume of 50µl. The immunoprecipitation 
experiments were performed as described above with the exception that radioactively labeled 
Sec20 was added to the extraction buffer. 
4.10.1.2. Disassembly experiments 
For SNARE-complex disassembly, the solubilized samples were treated or not with 50 
nM NSF and 2 µM α-SNAP in presence or absence of other components (ATP 5mM, EDTA 
2mM, MgCl2 8mM) for 1 h at 16°C. In parallel, excess amounts of antibodies against mUse1 
were incubated for 1 h at 4°C with sufficient quantities of protein A–Sepharose previously 
washed with extraction buffer. The mUse1 antibodies bound to protein A-Sepharose were 
then added to the different samples and incubated for 90 min at 4°C to allow the binding of 
antigen to the antibodies. The immunoprecipitation was then continued as described above. 
 
4.10.2. Live cell FRET experiment 
4.10.2.1. Principle of FRET 
FRET is a process in which energy is transferred nonradiatively (that is via long-range 
dipole-dipole coupling) from a fluorophore in an electronically excited state (donor), to 
another chromophore or acceptor. The latter may, but need not, be fluorescent.  
Fluorescence Energy transfer (FRET) is a principle used for quantifying the distance 
between two molecules conjugated to different fluorophores, one is the Donor molecule (D) 
and the other is the Acceptor molecule (A). The quantitative treatment of FRET originated 
with Theodor Förster [257]. It is described by the following parameters: kt which is the rate of 
radiationless energy transfer, the transfer quantum yield generally denoted as the energy 
transfer efficiency E and the Förster constant R0 which is the distance between the donor and 
acceptor probes at which E is 50% (see annex I for details). 
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 Conformational changes can also be monitored when both probes are present on the 
same molecule. 
4.10.2.2. Live cell FRET measurements 
Two ways are exploited in this work to register FRET in living cells.  
        (1)  measuring the increase of acceptor fluorescence upon excitation of the donor  
 (sensitized emission) 
        (2) measuring increased fluorescence of the donor (donor dequenching) after 
 photobleaching of the acceptor. 
These measurements were performed using both spectrofluorimetry and microscopy. 
 
4.10.2.2.1. Spectrofluorimetry : GFP2 / venus YFP as FRET pair 
For FRET measurement by spectrofluorimetry, GFP2 was used as donor molecule and 
venusYFP as acceptor molecule. The FRET pair GFP2 / YFP has been previously described 
by Zimmermann et al. [258]. It has an increased FRET efficiency compared to the most 
commonly used FRET pair consisting of CFP and YFP (Figure 6). Indeed, GFP2 has a higher 
quantum efficiency (Q= 0.55) compared to CFP (Q= 0.4) and a larger overlap integral with 
the YFP acceptor (66% for CFP-YFP and 87% for GFP2-YFP). Moreover, GFP2 has its 
excitation maximum at 396 nm at which wavelength the excitation of YFP is negligible. The 
fluorescence yield of venusYFP is higher than that of YFP [259] which makes it a better 
acceptor for FRET experiments and also allows to decrease protein overexpression without 
decreasing the fluorescent signal when using venusYFP. 
 
Figure 6: Left panel: Normalized 
spectra of the excitation (dashed 
lines) and the emission (solid lines) of 
GFP2 (green), CFP (blue) and YFP 
(yellow), respectively. Right panel: 
FRET efficiencies of the GFP2/YFP 
and CFP/YFP pairs derived from the 
spectral properties of the fluorescent 
proteins. FRET efficiencies for 
GFP2/YFP (green) and CFP/YFP 
(blue) are plotted as a function of the distance between the fluorescent proteins. Efficiencies at any distance are 
higher for GFP2–YFP than for CFP–YFP. The dotted line shows the relative increase in FRET efficiency for 
GFP2/YFP as compared to CFP/YFP [258]. 
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Vero cells were expressing either the FRET control construct GFP2-14AA-vYFP, 
considered as giving the maximum FRET value measurable in this assay, or co-expressing a 
GFP2 fusion protein and a venus YFP fusion protein. Cells co-expressing GFP2 and venusYFP 
were used as a negative control as well as cells co-expressing the medial-cis Golgi marker 3′-
phosphoadenylyl-sulfate:uronyl-2-O-sulfotransferase (2-OST) coupled to GFP2 and a 
lysosomal / endosomal transmembrane protein CD63 coupled to venusYFP. After 
transfection, Vero cells were grown in 10-cm dishes and on coverslips for expression level 
control. After 10 to 12 h for SNARE-proteins or 5 h when Erd2 was expressed, the protein 
expression was visualized with the Axiovert 200 microscope (described in Materials) using an 
excitation filter 405/20 nm, a dichroic beam splitter 440 nm and an emission filter 525/50 nm 
for GFP2 fusion proteins, and an excitation filter 500/20 nm, a dichroic beam splitter 515 nm, 
and an emission filter 535/30 nm for venus YFP fusion proteins. The cells were then collected 
with a cell scraper from a 10 cm dish in 500 µl of PBS and transferred into a quartz cuvette 
for spectrofluorimetry. The emission fluorescence intensities were measured for the donor 
(GFP2) after excitation of the sample at λ = 390 nm and for the acceptor (venusYFP) after 
excitation of the sample at λ = 498 nm with a Cary spectrofluorimeter using the program 
Eclipse (provided by Varian). The spectra were acquired before and after acceptor bleaching 
which was performed with an Argon laser (Innova 70 from Coherent) emitting at 530 nm 
while stirring the sample. The wavelength λ= 530 nm ensures that GFP2 (maximum excitation 
396 nm) is negligibly bleached (see annex II). The spectra obtained with the program Origin 
where corrected for cell autofluorescence and GFP2 bleedthrough into the FRET channel. The 
effect of vYFP bleedthrough on the FRET signal is negligible as there is no direct excitation 
of vYFP at 390 nm. Normalized FRET values were calculated with Excel according to the 
equation given below in the analysis chapter (2.10.2.3). The results obtained were shown on a 
graph (designed with Sigma plot) representing the NFRET values for various transfections. 
  
4.10.2.2.2. Microscopy : CFP / YFP as FRET pair. 
The high absorption and quantum yield of YFP [260]make it or its improved variants 
[259]an attractive FRET acceptor. However, it has limitations for FRET microscopy in its use 
in combination with optimal donors such as EGFP or GFP2. Donor and YFP emission spectra 
show significant overlap, which makes it difficult to separate and quantify the emitted light of 
the donor and the acceptor. Therefore, the CFP-YFP FRET pair was used for this experiment.  
Vero cells were plated in 10 cm dishes and cultured in complete DMEM. After 48 
hours cells were co-transfected by electroporation with plasmids coding for the indicated 
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proteins fused either to CFP or to YFP and grown on coverslips in 6-well plates. Cells 
expressing CFP-15AA-YFP were considered as giving the maximum FRET values detectable 
in this type of experiment and cells co-expressing CFP and YFP were used as negative 
control. After expression for 5 to 8 hours for Erd2 or for 12 to 16 hours for other proteins, 
transfected cells were transferred to a chamber with 600µl of HAM´s F-12 medium. FRET 
measurements were then performed using the inverted microscope described before and 
equipped with a 37°C thermostated incubator and a 5% CO2-air mix system (figure 7).  
 
Figure 7: Optical scheme and 
experimental conditions for FRET 
measurement with an Axiovert 200 
microscope.  An incubator and a system with 
CO2-air mix were installed on the microscope 
to maintain the cells viable during the 
experiment. A laser pointer was inserted into 
the optical path of the microscope to allow 
acceptor bleaching in a region of interest 
(ROI) in the cell. 
 
 
CFP was detected using a filter set composed of an excitation filter 436/20 nm, a 
dichroic beam splitter 455 nm, and an emission filter 480/40 nm; for YFP an excitation filter 
500/20 nm, a dichroic beam splitter 515 nm, and an emission filter 535/30 nm were used; the 
FRET filter set consisted of an excitation filter 436/20 nm, a dichroic beam splitter 455 nm 
and an emission filter 535/30 nm.  
 Images were acquired into the 3 channels before and after acceptor bleaching which 
was performed by applying for 1 min to the cell or a cell region of interest a 532 nm low-
power laser inserted in the optical path of the microscope (figure 7). The wavelength λ= 
532nm ensures that CFP is negligibly bleached. A filter set, composed of a dichroic beam 
spliter (595 nm) and a long pass emission filter (570 nm), was used to follow the YFP 
bleaching.  
The results were analysed as described in the analysis chapter (2.10.2.3). The results 
obtained were shown on graphs (designed with Sigma plot) representing the normalized 
FRET values for various transfections. 
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4.10.2.3. Analysis 
Steady-state FRET measurements can suffer from several sources of distorsion, which 
need to be corrected for. A simple method, based on the modified Gordon method [261] 
[262], was used for analysis of FRET data, obtained as described above This method corrects 
for cross-talk between donor fluorescence and acceptor fluorescence and between FRET 
fluorescence and non-FRET fluorescence emitted from donor and/or acceptor, and for the 
dependence of FRET on the concentrations of the donor and the acceptor. 
In the Gordon method mentioned below, the FRET value FRETN is representative for 
FRET signals [261]. However, it is limited to samples with comparable donor and acceptor 
concentrations. Moreover, with this method the authors consider that all the donor- and 
acceptor-fusion proteins are involved in energy transfer in case of interaction. However, it is 
likely that free donor- and acceptor-fusion proteins are present in the cell which cannot 
contribute to the resulting FRET signal. In a recent study, Xia and Liu [262] attempted to 
provide a reliable FRET value called Normalised FRET value (NFRET) that is also useful for 
comparison between different cells or samples by arbitrarily inserting a square root of the 
product (IA ● ID), with  IA and ID corresponding to the fluorescence intensities in the acceptor 
(YFP or vYFP) and in the donor (CFP or GFP2) channels respectively. In this way, the 
dependency of the FRET signal on the donor and acceptor concentrations is reduced and 
closer to reality.  
 
FRETN = (IFRET – IA ● y – ID ● z) / (IA ● ID)  (Gordon G.W. et al., 1998) 
 
  
NFRET = (IFRET – IA ● y – ID ● z) / √ (IA ● ID)  (Xia Z. And Liu Y., 2001) 
 
where  IFRET is the fluorescence intensity in the FRET channel and y and z correspond to 
acceptor and donor bleed through emissions respectively, into the FRET channel. 
 
To confirm that a FRET signal results from specific interaction between the proteins 
of interest, acceptor photobleaching can be performed as explained before. When two proteins 
interact leading to energy transfer, the donor fluorescence after acceptor photobleaching 
represents the total amount of donor-fusion proteins expressed in the cell. It is therefore more 
accurate to consider this value (IDab) to correct for the donor concentration. This led to the 
following equation used in this work:  
 
NFRET = (IFRET – IA ● y – ID ● z) / √ (IAbb ● IDab)  
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where  IAbb  is the acceptor fluorescence intensity before bleach 
and  IDab is the donor fluorescence intensity after bleach 
 
For the spectral data, the results were analysed with the programs Origin 7.0 and 
Excel. The values of interest (emission fluorescence intensity at 510 nm and 526 nm when the 
sample is excited at the donor excitation wavelength at 390 nm) were corrected for 
background. The bleed through of GFP2 (called z in the formula) was estimated to be about 
42% by acquiring spectra of cells expressing GFP2 fusion protein alone. The bleed through of 
vYFP (called y in the formula) was negligible since it is not directly excited at 390 nm (see 
Annex II). 
For fluorescence microscopy, the results were analysed according to this formula 
using the program Imspector provided by Dr. Andreas Schönle. The images were corrected 
for background, pixel-shift and cross-talks (also called bleedthroughs). The cross-talks 
between CFP and YFP channels were negligible. The bleed through of CFP (called z in the 
formula) and YFP (called y in the formula) into the FRET channel were about 56% and 4% 
respectively, under our conditions. This estimation was done by taking pictures, in each 
channel, of cells overexpressing CFP fusion protein and YFP fusion protein alone in the cells. 
To define the perinuclear and the peripheral regions, the picture given for the YFP 
fluorescence was taken as reference. The signal intensity scale was set to saturation limit. The 
region where the fluorescent signal values exceeded 50 % of the maximal signal was defined 
as the perinuclear region and the values below were considered to represent the peripheral 
region.  
The results obtained with both spectrofluorimetry and microscopy, were expressed 
using Sigma Plot on a graph showing the NFRET values for the different samples.  
 
4.10.3. BiFC experiments 
 
The Bimolecular Fluorescence Complementation (BiFC) approach has been recently 
described by Hu and Kerppola [263]. It is based on the formation of a fluorescent complex by 
fragments of the enhanced yellow fluorescent protein. They identified nonfluorescent 
fragments of YFP that could reconstitute the fluorophore only when brought together by 
interactions between proteins covalently linked to each fragment. 
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One of the advantages is that BiFC analysis allows 
direct visualization of protein interactions in their 
normal cellular environment and the interpretation of 
the results does not require complex data processing. To 
construct mammalian expression vectors for 
bimolecular fluorescence complementation (BiFC) 
analyses, enhanced yellow fluorescent protein EYFP 
was dissected into an N-terminal fragment containing 
amino acids 1–172 (YN) and a C-terminal fragment containing amino acids 173–238 (YC) as 
described by Hu et al. [263]. The fragments were amplified by PCR from pEYFP (Clontech) 
using the following primer pairs: for pC1-YN 5´-TATTATACCGGTCATGGTGAGCAAGG 
GCGAGGAGCTG-3´ (forward) and 5´- TATTATAGATCTGATGTTGTGGCGGATCTTG 
AAGTT-3´ (reverse) for pC1-YC 5´-TATTATACCGGTCATGGAGGACGGCAGCGTGCA 
GCTCGCG-3´ (forward) and 5´-TATTATAGATCTCTTGTACAGCTCGTCCATGCCGAG-
3´ (reverse). The PCR introduced an Age I site at the 5′ end and a BglII site at the 3′ end. This 
allows exchange of full-length GFP (amino acids 1–238) from pEGFP-vector against the YN 
and YC fragments.  
Different SNARE mutants lacking most of their cytoplasmic parts (Sec20d194, Use1d234 and 
Sec22-d189), Use1 lacking only its SNARE motif and Sec22 containing point mutations, 
were constructed and used in the following approach. 
Each of our proteins of interest was subcloned into the different vectors and 
transfected pairwise into Vero cells together with pC1-CFP which was taken as reference for 
expression level of the fluorescent proteins. Cells were grown on coverslips for 24 h and 
imaged in PBS at 37°C. CFP and the reconstituted YFP were detected using the same filter 
sets previously used for CFP and YFP for the FRET experiments. Images were acquired and 
analysed with MetaMorph 6.0.  
The results were calculated using Excel according to the following equation:  
 
  ratio RBIFC = (IYFP – α * ICFP) / ICFP  
 
where  RBIFC represents the emission fluorescent signal of the reconstituted YFP,   
and α corresponds to the CFP bleed through into the YFP channel (equal to 5%) 
The results obtained are shown on a graph designed with Sigma Plot and were analysed 
for statistical relevance with the Mann and Whitney test (Matthias Wilmann). 
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4.11. In vitro vesicle release assay from isolated rat liver Golgi 
 
Golgi stacks were prepared according to Hui et al. [264]. Briefly, rat livers were cut into 
small pieces in 0.5 M sucrose in 0.1 M phosphate, pH 7.4 and pressed through a 120 µm mesh  
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sieve. The homogenate was layered over 0.86 M sucrose, 0.1 M phosphate, pH 7.4 and spun 
at 141,000 x gav for 1 h. The fractions at the 0.86 M/0.5 M interphase were collected, adjusted 
to 0.5 M sucrose and layered on top of 0.86 M sucrose in 0.1 M phosphate, pH 7.4, and spun 
at 120,000 x gav (SW 41 rotor) for 45 min. Membranes from the 0.86M/0.5M sucrose 
interphase were collected, adjusted to 0.25 M sucrose, layered on top of 1.3 M sucrose/0.1 M 
phosphate, pH 7.4, and spun at 10,000 x gav (SW 41 rotor) for 30 min. The Golgi membranes 
were finally collected from above the 1.3 M sucrose cushion. 
Vesicles were released from Golgi under the conditions described in the scheme. For all 
the samples, Golgi membranes corresponding to 300 µg protein were incubated in phosphate 
buffered sucrose. All samples contained 5 mM Mg acetate and 100mM potassium glutamate. 
Samples were then centrifuged at 15,000 x gav for 20 min to sediment the Golgi membranes. 
The supernatant was spun for 1 h at 130,000 x gav to obtain the vesicles in the sediment. 
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The contents of the different fractions were analysed by western blot and immuno-
electron microscopy (Dirk Wenzel, EM facility, Max-Planck Institut Biophysical Chemistry). 
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5. RESULTS 
 
5.1. Mammalian Golgi-to-ER SNAREs homologs 
 
A SNARE complex involved in the Golgi-to-ER retrograde transport has been recently 
described in yeast as composed of Sec22p, Ufe1p, Use1p and Sec20p [85]. Mammalian 
homologs of Sec22p and Ufe1p were already known as Sec22b [265]and Syntaxin18 [222] 
respectively. To know whether a similar complex exists in mammals, we searched the NCBI 
database to identify possible mammalian homologues for Use1p and Sec20p. We found one 
sequence for each protein that we named Use1 (from rat) and Sec20 (from mouse). While this 
work was in progress, Hirose et al. [227] and Nakajima et al. [226] reported the sequences of 
the respective human orthologs of Use1p and Sec20p that they called p31 and BNIP1 
respectively. The sequence identity between yeast and the corresponding mammalian 
sequences is significant for all 4 SNARE proteins (fig.8), although it is very low for Sec20. 
The N-terminal extension of mSec20 is 67 amino acids shorter than that of Sec20p. Moreover, 
in comparison to mouse Sec20, Sec20p has an 84 amino acid C-terminal extension with a 
retrieval signal HDEL. The N-terminal domain of Syntaxin18 is involved in the interaction 
with SLY1 which can open the closed conformation of Syntaxin18 before and/or during the 
assembly of the t-SNARE complex [133, 266, 267]. mSec22b, as well as Ykt6, have a so 
called “longin” domain as N-terminal extension [268, 269]. Sec22b is likely to adopt an open 
conformation [270], while Ykt6p adopts a back folded (closed) conformation in which the N-
terminal profilin-like domain binds to its C-terminal SNARE domain [229]. The N-terminal 
extensions of Sec20 and Slt1 remain to be characterized.  
 
SNARE proteins have been structurally classified according to the central residue of the 
SNARE motif (0-layer). They can be designated as R-SNAREs and Q-SNAREs which can be 
sub-classified as Qa, Qb and Qc (see Introduction, chapter 1.3.2). Classically, a ternary 
SNARE complex as described for the synaptic vesicle [82] contains at its 0-layer one arginine 
and three glutamines. Among the four SNARE-proteins studied in this work, Sec22 is an R-
SNARE, Syntaxin 18 is a Qa-SNARE and USE1 and Sec20 contain respectively an aspartate 
(D) and a serine (S) at their 0- layer. Based on the homology of SNARE motif sequence 
between these SNAREs and the mammalian Qb- and Qc-SNAREs which are known to be 
involved in the formation of a SNARE complex, (such as the synaptic complex, the 
endosomal complex and the ER to Golgi forward complex, figure 9A), we suggest that USE1 
is the Qc-SNARE and Sec20 is the Qb-SNARE in the Golgi-to-ER retrograde transport 
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SNARE complex (figure 9B). USE1 as a Qc-SNARE was also suggested by Hong W. [80] 
but in his classification Sec20 remained difficult to define.  
 
 
 
 
Figure 8: Amino acid sequence alignment of yeast SNAREs involved in Golgi-to-ER retrograde transport and 
their mammalian homologues identified and used in this study. Red and yellow squares represent identical and 
similar amino acids respectively, with the following groupings considered similar: R and K; Q and N; T and S; E 
and D; and V, I, L, F, and M. Pairwise comparisons of yeast and mammalian SNAREs yielded the following 
results: Sec22 Mm. (Mus musculus) shows 44 % homology (37 % identity) with Sec22 Sc. (Saccharomyces 
cerevisiae); Syntaxin 18 Hs. (Homo sapiens) versus Ufe1 Sc. and Use1 Rn. (Rattus norvegicus) versus Use1 Sc. 
show 26 % homology (17 % identity) ; and  Sec20 Mm. shows 15 % homology (8% identity) with Sec20 Sc.  
Note that Syntaxin 18 Hs. and Syntaxin 18 Mm. are highly similar and that USE1 Rn. and USE1 Mm. are 100% 
identical. The black frames highlight the SNARE motifs. The numbers below the black frames represents the 
layers of contacting residues on the inner surface by homology with the synaptic complex. 
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Figure 9: (A) Amino Acids sequence alignment of SNARE-motifs of mammalian SNARE-proteins. Syntaxin1a 
(Sx1a), SNAP25 (N), SNAP25 (C) and Synaptobrevin2 (Sb2) are involved in the synaptic complex. Syntaxin7 
(Sx7), Vti1b, Syntaxin8 (Sx8) and Endobrevin (Eb) compose the early endosomal SNARE complex. Syntaxin5, 
membrin, mBet1 and mSec22b form a SNARE complex involved in ER-to-Golgi transport. Syntaxin18 (Sx18), 
mSec20, mUse1 and mSec22b are the candidates for forming a retrograde Golgi-to-ER SNARE complex. 
The numbers below and above the sequences represent the layers of contacting residues on the inner surface as 
in figure 8. The red and blue letters represent the amino acid of the zero layer and of the other layers 
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respectively. The letters in green show the amino acids involved in salt-bridge formation. (B) This scheme 
represents a hypoyhetical structural view of the zero layer of the putative Golgi-to-ER complex by homology 
with the synaptic complex crystal structure [82]. 
 
5.2. Purity of the proteins and of the antibodies produced and used in this study 
 
To produce antibodies, all proteins were expressed and purified as described in the 
methods part and samples run on SDS-gel (12%).  
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5.3. Expression level and localization of endogenous proteins and various 
overexpressed GFP-fusion proteins expressed in Vero cells. 
 
To determine whether the GFP fusion retrograde Golgi-ER SNARE-proteins were 
properly localized, they were overexpressed in Vero cells and their localization as compared 
to that of the corresponding endogenous proteins. When Sec22, Sec20 and Use1 are N-
terminally fused to a GFP variant they show the same steady-state distribution as the 
endogenous WT-proteins. Indeed, YFP-Use1 and YFP-mSec20 exhibit the same ER-
localization as the endogenous WT-proteins and the majority of YFP-mSec22b is found in the 
Golgi as is the endogenous mSec22b (figure11). However, the distribution of YFP-syntaxin18 
varied between different experiments and did not show the same reticular distribution as the 
endogenous syntaxin18, especially when co-expressed with other GFP variant fusion SNARE 
protein. Therefore, we omitted experiments with syntaxin18 GFP fusion protein in the 
following FRET studies. 
mUSE1mSec20mSec22B Syntaxin18
10 µm
(Hatsuzawa K. et al., 2000)
Endogenous
protein
GFP fusion 
protein
A 
 
B 
Figure 11. Endogenous and YFP fusion SNARE proteins 
expressed in Vero cells. Vero cells were transfected (lower 
panel) or not (upper panel) to express YFP fusion SNARE-
proteins. Untransfected cells were immunostained for the 
indicated SNARE-proteins and transfected cells were observed 
10 to 12 hours after transfection by microscopy (A). The localization of the fusion proteins is similar to that of 
the endogenous proteins. Untransfected (Cont.) and transfected (Sec22-YFP, Use1-YFP or Sec20-YFP) cell 
lysates were also analysed by western-blotting (B).   
Cont. 
 Use1- 
 YFP Cont.
Sec20- 
 YFP 
Sec22- 
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The degree of overexpression was roughly estimated by western blotting comparing the 
amount of overexpressed and endogenous proteins in transfected Vero cells. The expression 
level of the endogenous proteins was corrected considering the transfection efficiency which 
was estimated to be 65%. mSec22b-YFP was about 2 times more abundant than the 
endogenously expressed mSec22b in Vero cells whereas the amount of mUse1-YFP and 
mSec20-YFP was about 14 times higher than that of their respective endogenous protein. For 
Use1-YFP, the bands observed below the highest band (reprenting Use1-YFP) on the 
membrane are most probably degradation products from the fusion protein meaning that the 
overexpression factor calculated above is in reality slightly higher than 14. 
 
The localisation of the endogenous proteins was further studied using specific markers 
for ER (calnexin), ERGIC (ERGIC53) and Golgi (2-OST). 
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igure 12: Localisation of the endogenous 
NARE-proteins in Vero cells. Rabbit polyclonal 
ntibodies were used to detect the SNAREs and 
ouse monoclonal antibodies were used to detect the 
arkers calnexin, which is a transmembrane ER 
arker, and ERGIC53, which is a marker for the 
ntermediate compartment (IC). The sulfotransferase 
-OST was expressed as GFP-fusion protein to label 
he Golgi apparatus (ST-GFP). The SNARE-protein 
f interest (mSec22b (A), mUse1 (B) and mSec20 
C)) is shown in red and the organelle specific 
arker in green. Both pictures were then overlayed 
ellow colour on the picture. 
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Interestingly, the distribution of mSec22b is very similar to that of ERGIC53, it shows 
significant overlap with the Golgi marker 2-OST but only very little with the ER marker 
calnexin. mUse1 co-localises only partially with ERGIC53 but significantly with calnexin. No 
or very little mUse1 protein was found in the Golgi. A low concentration of mSec20 seems to 
be evenly distributed between the ER and the Golgi, but does not appear to be present in the 
ERGIC eventhough it is difficult to estimate as when ERGIC53 antibodies were used with 
mSec20 antibodies the ERGIC staining was not typical. The staining for mSec20 shows 
punctuated structures which are dispersed throughout the cell and need to be further 
characterized. 
 
5.4. Detection of interactions between Sec22, Sec20 and Use1 with live cell FRET 
spectroscopy. 
 
The Golgi-to-ER yeast SNARE proteins Sec22p, Use1p, Ufe1p and Sec20p were 
shown to form a SNARE complex [91] by co-immunoprecipitation. In order to know whether 
interactions between the mammalian homologues of these SNARE proteins occur in living 
mammalian cells we performed live cell FRET experiments. FRET allows to measure short 
distances between two molecules. The distances must be comprised between 1 and 7 nm and 
indicate interaction (if stochastic FRET signals can be excluded). One advantage of GFP-
based FRET is its ability to study protein-protein interactions in a physiological environment 
[271, 272]. It provides the potential to measure the interaction of molecular species in intact 
living cells where the donor and acceptor fluorophores are actually part of the molecules 
themselves.  
Reliable positive and negative controls are essential for the accurate quantification of 
FRET. For negative controls, Vero cells were transfected to co-express either the donor GFP2 
together with the acceptor VenusYFP or two markers localised in two distinct organelles and 
fused one to GFP2 and the other to venusYFP. As positive control, a protein composed of the 
two fluorescent protein moieties separated by a short spacer (14 amino acids) was expressed 
in Vero cells. After 10 to 12 hours, the measurements were performed and the results analysed 
as described in the methods.  
In experiments involving GFP fusion proteins, overexpression of the recombinant 
proteins may result in nonspecific interaction between the donor and the acceptor. Purified 
GFP has been shown to dimerize at extremely high concentrations (> 4 µM) in vitro [273]. In 
our current system, however, only negligible FRET signals were measured due to nonspecific  
  69 
 Results 
___________________________________________________________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
E F 
C D 
A B 
Figure 13a: Spectra obtained for the negative and positive FRET controls. Vero cells were co-expressing 
GFP2 and venusYFP (upper panel: A and B, respectively) or ST-GFP2 and CD63-VenusYFP (middle panel: C 
and D, respectively) and used as negative controls. ST is a medial-cis Golgi marker and CD63 is a lysosomal / 
endosomal membrane protein. Vero cells expressing the construct GFP2-14AA-vYFP (lower panel: E and F) 
were used as positive control. Suspensions of transfected cells were excited (left column: A, C and E) at λex=390 
nm and subsequently (right column: B, D and F) at λex= 498 nm and emission spectra were acquired (blue line). 
The spectra obtained were analyzed according to the equation given in the Methods part. 
 
interactions between GFP2 and venusYFP (Fig.13a upper panel). The same holds for cells co-
expressing the medial-cis Golgi marker [274] 2-OST fused to GFP2 (ST-GFP2) and the 
lysosomal / endosomal transmembrane protein CD63 fused to VenusYFP (CD63-vY) 
(Fig.13b middle panel). Indeed, in both cases, the spectrum did not show a FRET peak at 526 
nm (Fig. 13a, A and C), and the normalized FRET values (NFRET, see methods) obtained for 
the two samples were equal to 0.040 ± 0.002 and 0.02 ± 0.018, respectively, corresponding to 
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approximately 8 % of the mean value obtained for the cells expressing GFP2-14AA-vYFP 
(NFRET = 0.36 ± 0.02) (Fig.13 C). The latter is taken as the maximum FRET value which can 
be obtained in our system as high intensity emission peak at λ=526 nm (Fig. 13a E).  
Vero cells were then transfected to express GFP2- and VenusYFP-SNARE proteins 
pairwise (Use1-GFP2 and Sec22-vYFP, Use1-GFP2 and Sec20-vYFP or Sec22-GFP2 and 
Sec20-vYFP).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
E F 
C D 
A B 
Figure 13b: Spectra obtained for different pairs of SNARE-fusion proteins. Suspensions of cells co-
expressing Use1-GFP2 and Sec22-vYFP (upper panel: A and B), Use1-GFP2 and Sec20-vYFP (middle panel: C 
and D) or Sec22-GFP2 and Sec20-vYFP (lower panel E and F) were excited at 390 nm (left panel: A, C and E) 
and subsequently at 498 nm (right panel: B, D and F), the excitation wavelengths for GFP2 and venusYFP 
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respectively. Emission spectra were acquired before (blue line) and after (red line) acceptor photobleaching.  The 
spectra obtained were analyzed according to the equation given in the Methods part. 
 
Under steady-state conditions, the spectra measured for the different SNARE-pairs 
using the excitation wavelength λ=390 nm showed a significantly elevated intensity peak at 
526nm (Fig. 13b, A, C and E; blue line). After acceptor bleaching (shown in Figs. 13b, B, D 
and F), this peak disappeared, but donor fluorescence measured at λ=510nm increased (Fig. 
13b, A, C and E; red line). Thus, the peak observed at 526 nm before acceptor bleaching was 
the result of an energy transfer between the two fluorescent proteins due to the interaction or 
close proximity of the SNARE-proteins. The normalized FRET values calculated for the three 
SNARE-pairings (GFP2-mUse1 and VenusYFP-mSec22b, GFP2-mUse1 and VenusYFP-
mSec20, and GFP2-mSec22 and VenusYFP-mSec20) amounted to around 0.22. These values 
are significantly higher (~ 7 times) than the FRET values obtained for the negative controls 
and represent approximately 60% of the maximum FRET value obtained with the G2-14AA-
vY control construct (Fig. 13c). The KDEL-receptors (Erd2) which are present in the Golgi-
ER system are known to oligomerise depending on the degree of overexpression and 
occupancy by KDEL-proteins. As a second positive control, Vero cells were transfected to co-
express Erd2-vYFP and Erd2-GFP2 and the samples were used for FRET measurements (Fig. 
13c). 
 
 
 
 
 
 
 
 
 
Figure 13c: Graph representing the normalized FRET values obtained by spectrofluorimetry for various 
partners. G2 and vY are the donor (GFP2) and the acceptor (venusYFP), respectively. G2-14AA-vY is a control 
construct localized in the nucleus and the cytoplasm. Erd2 is the KDEL receptor; S22, S20 and Use1 are the 
SNARE candidates; ST stands for 2-O-sulfotransferase which is a medial-cis Golgi marker; CD63 is a 
lysosomal/ endosomal membrane protein. pN3G2 and pC1vY are the plasmids coding for each fluorophore. The 
normalized FRET values were obtained as described in the Methods part. The values given are mean values ± 
standard deviation of at least 5 independent transfections. 
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5.5. Localization of the specific interactions between Sec22, Sec20 and using with 
live cell FRET and BiFC imaging. 
 
5.5.1. Single live cell FRET microscopy. 
 
To estimate the intracellular distribution of the FRET-signals, we performed FRET-
measurements in single living cells. For this type of experiment, an inverted fluorescence 
microscope with three filter-sets was used: one to measure the donor fluorescence, one to 
measure the acceptor fluorescence and one to measure the FRET signal. Important cross-talks 
were observed when using the FRET pair GFP2 / venusYFP. In this case, the most commonly 
used FRET pair CFP/YFP showed less cross-talk and thus was used for this system. As 
negative control, Vero cells were transfected to co-express the donor CFP together with the 
acceptor YFP and as positive control, Vero cells expressed the construct CFP-15AA-YFP in 
which the two fluorescent protein moieties are separated by 15 amino acids. Ten to twelve 
hours after transfection, the measurements were performed, and the results were analysed as 
described in the Methods part.  
 
A:  CFP/YFP 
B: CFP-15AA-YFP 
Figure 14a: Images obtained for the negative and 
positive FRET controls. Vero cells were co-expressing 
CFP and YFP (A) and used as negative controls. Vero 
cells expressing the construct CFP-15AA-YFP (B) were 
used as positive controls. Images were acquired in the 
YFP channel (left column), in the CFP channel (middle 
column) and in the FRET channel (right column), before 
(bb, upper panels) and after (ab, lower panels) acceptor 
photobleaching. The pictures obtained were analyzed as 
given in the Methods section and NFRET was calculated 
using equation 1 (see Methods part). The intensity of the 
pictures taken in the CFP channel is represented by a false 
colour scale (red-orange-yellow). The blue colour 
indicates that fluorescence intensity at or above saturation. 
 
 
In single cell experiments, very low FRET signals could be observed resulting from 
nonspecific interactions between CFP and YFP (Fig.14a, A). Indeed, the normalized FRET 
value (NFRET, see Methods) calculated was 0.015 ± 0.018, corresponding to approximately 3,5 
% of the value obtained for the cells expressing the control construct CFP-15AA-YFP 
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(Fig.14a, B; NFRET = 0.447 ± 0.055). As in the spectrofluorimetry experiments, this NFRET 
value was taken as the maximum FRET value obtainable in our system (Fig. 14b D). The fact 
that the FRET signals obtained represent true sensitised emission is supported by the increase 
of donor (CFP) fluorescence intensity (picture CFPab, panel B) after acceptor (YFP) 
photobleaching (YFPab, panel B). 
 
 
Vero cells co-expressing SNARE-pairs (mUse1-CFP/mSec22b-YFP (A), mUse1-
CFP/mSec20-YFP (B) and mSec22b-CFP/mSec20-YFP (C)) were also analysed by single-
cell FRET microscopy. In all cases, the overall FRET-values obtained were significantly 
higher than the one obtained for the negative control pair CFP/YFP. Moreover, in each 
sample, YFP photobleaching led to an increase of CFP intensity (picture CFPab, panels A, B 
and C) confirming that energy transfer had occurred between the two proteins. Interestingly, 
the NFRET values measured in the periphery of the cells were always higher than in the 
perinuclear area (Fig.14b), which could indicate an increased interaction between the 
SNARE-proteins when they are close to, or in, the ER. Except for the pair mSec22b/mSec20, 
the NFRET values in the perinuclear region were close to the negative control suggesting that 
Use1 interacts with mSec22b and mSec20 almost exclusively in the cell periphery. This 
would fit with the localisation of the endogenous SNARE-proteins reported above (see 
chapter 5.3., Fig. 12).   
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Figure 14b: Vero cells co-expressing USE1-CFP and Sec22-YFP (A), USE1-CFP and Sec20-YFP (B), or 
Sec22-CFP and Sec20-YFP (C) were grown on coverslips. Images were acquired in the YFP channel (left 
column), in the CFP channel (middle column) and in the FRET channel (right column), before (bb, upper row) 
and after (ab, lower row) acceptor photobleaching. The intensity of the pictures taken in the CFP channel is 
represented using an artificial colour scale (red-orange-yellow). The blue colour appears when the fluorescence 
intensity was at or above saturation. (D) Graph showing the normalized FRET values obtained (see Materials 
and Methods) for the hetero SNARE pairs and homo SNARE pairs (Sec22-CFP/Sec22-YFP, USE1-CFP/USE1-
YFP and Sec20-CFP/Sec20-YFP), for the positive control (CFP-15AA-YFP) and for the negative control (pC1-
CFP/ pC1-YFP). Note that for the hetero-SNARE pairs a perinuclear ER FRET signal (N) and a peripheral 
FRET signal (P) could be distinguished within each cell. The values given are mean values ± standard deviation 
of three independent experiments, each analyzing at least 10 cells. 
 
To ensure that the FRET signal observed is not due to ER membrane crowding 
resulting simply from overexpression, CFP- and YFP-fusions of the same SNARE-protein 
were co-expressed in Vero cells. Co-expression of mSec22b-CFP and mSec22b-YFP led to a 
weak FRET signal comparable to the one obtained from co-expressed soluble CFP and YFP 
indicating that there is little homotypic interaction between mSec22b proteins (Fig.14a). 
However, co-expression of mUse1-CFP and mUse1-YFP as well as co-expression of mSec20-
CFP and mSec20-YFP resulted in a significant FRET signal (Fig.14b, 0.058 ± 0.016 and 
0.043 ± 0.019, respectively). This suggests that these Q-SNAREs partially homo-oligomerize. 
Interestingly, in those cases, the distribution of the FRET signal was homogenous throughout 
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the ER. Surprisingly, for the pair mSec20-CFP/mSec20-YFP 30% of the measured cells did 
not show any FRET signal. To further investigate the nature of the homo-oligomerisation, 
mUse1-CFP was co-expressed with mUse1∆(184-234)-YFP (deleted for the SNARE motif) 
in Vero cells. The NFRET mean value (0,054 ± 0.029) obtained in this case was almost equal to 
the one obtained for the wild-type pair indicating that mUse1 does not homo-oligomerise via 
the SNARE-motif. For mSec20, the co-transfection of plasmids coding for mSec20-CFP and 
mSec20∆(1-194)-YFP led to cells which expressed much more of mutant than of wild-type 
protein, making it difficult to properly perform FRET measurement. 
 
5.5.2. Bimolecular Fluorescence Complementation (BiFC). 
 
The most widely used approach for the visualization of protein interactions in living 
cells is
 
 FRET. As an alternative, Hu and Kerppola [263] recently developed an approach 
called Bimolecular Fluorescence Complementation (BiFC, described in the Methods section). 
In this method, a fluorescent signal is observed only when a complex between two proteins is 
formed (for illustration see the methods section). One of the advantages is that BiFC analysis 
allows direct visualization of protein interactions in their normal cellular environment without 
requiring complex data processing. To apply this method to this study, Vero cells were 
transfected to co-express CFP with either the pair Sec22-YN/Sec20-YC, USE1-YN/Sec20-
YC or USE1-YN/Sec22-YC. These vectors encode for Sec22-, Sec20- and USE1-fusion 
proteins which carry either the N-terminal part of YFP (-YN) or the C-terminal part of YFP (-
YC). When mSec22b linked to the N-terminal YFP fragment (Sec22-YN) was co-expressed 
together with mSec20 linked to the C-terminal YFP fragment (Sec20-YC), reconstituted YFP 
fluorescence was detected in the cells, most likely in the endoplasmic reticulum (Fig.15a, A). 
The same holds for the corresponding co-expression of mUse1-YN/mSec20-YC (Fig.15a, B) 
and mUse1-YN/mSec22b-YC (Fig.15a, C). Importantly, Vero cells expressing only one of 
these YFP-fragment fusion proteins did not show any YFP-fluorescence. Moreover, assembly 
of the YN- and YC-fragments alone resulted only in negligible YFP fluorescence. Thus, the 
occurrence of YFP fluorescence demonstrates a specific interaction between the SNAREs 
studied. 
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Figure 15a: Visualization of SNARE interactions 
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transfected with the plasmids coding for the indicated 
SNARE proteins (top part of the picture panels). CFP 
was used as a reference for the protein expression 
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measurements were done 24 hours after transfection 
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The formation of salt-bridges between the C terminal SNARE motif of SNAP25 and 
synaptobrevin (Sb2) has been shown to be essential for the synaptic SNARE complex 
formati
 corresponding SNARE proteins, we have expressed these mutants as fusion 
protein
on implying the residues SNAP25-R161/Sb2-E41 and SNAP25-D186 /Sb2-R66 [82]. By 
homology, Joglekar et al. [107] reported that the interaction between the ER-Golgi 
anterograde SNAREs mBet1 and mSec22b might involve salt bridge formation between 
mBet1-K47 and mSec22b-D144, and mBet1-D72 and mSec22b-K169. According to the 
alignment of SNARE motif sequences, lysine195 and aspartate220 exist in the SNARE-motif of 
mUse1 in similar positions to the corresponding amino acids in the SNARE-motif of mBet1 
(Fig. 9A). We, therefore, considered that a similar salt bridge formation might be involved in 
the interaction between mSec22b and mUse1. Therefore, we co-expressed the N-terminal 
fragment of YFP fused to a doubly mutated mSec22b (D169A, K144D) with WT-mUse1 
fused to the C-terminal fragment of YFP. These mutations in mSec22b were sufficient to 
induce a clear left shift in the histogram (Fig.15a D) indicating a decreased interaction 
between the two SNARE proteins. The Mann and Whitney test (performed by Matthias 
Willmann) applied on these results gave a very high probability (p< 0.0001) for the results not 
to be accidental. 
As the truncations and deletions applied here could have affected the intracellular 
localisation of the
s with full length YFP and analysed their localisation in comparison to the 
corresponding wt-SNARE. This was done 24 hours after transfection as for the BiFC 
experiments. Deletion of the N-terminal 194 amino acids (which includes the SNARE-motif) 
did not affect the ER-localisation of mSec20 (Fig.15b, A). In contrast, truncation of the N-
terminal portion (including the SNARE-motif) of mUse1 abolished its retention in the ER. 
Instead the truncated protein appeared in the Golgi 8 hours after transfection and finally in the 
plasma membrane 24 hours after transfection (Fig.15b, B). This does not result from the loss 
of the SNARE motif as deletion of the SNARE motif alone did not change the steady-state 
distribution of mUse1 in comparison to that of WT-mUse1 (Fig.15b, B right picture). Thus, 
retention of mSec20 in the ER requires mainly, if not exclusively its transmembrane domain, 
whereas in case of mUse1 the N-terminal portion upstream of the SNARE-motif is required 
for proper localisation. 
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Figure 15b: Effect of various mutations on the intracellular localisation of SNARE-proteins. The drawings 
depict the different constructs expressed in Vero cells: the yellow part represents YFP, the light blue part the 
protein sequence, the red rectangle is the SNARE motif and the blue rectangle the transmembrane domain. The 
pictures show the expression pattern of the indicated proteins (wt and corresponding mutants) after expression 
for 8 or 24 hours (A: mSec20; B: mUse1 and C: mSec22b). 
 
For mSec22b, truncation of its N-terminal 189 amino acids (including the SNARE-
motif) changed the distribution of YFP-mSec22b in comparison to the wt-fusion protein 
(Fig.15b, C): 8 hours after transfection, an accumulation of the protein in the Golgi was 
observed and this effect was even stronger 16 hours later. In this case, the transmembrane 
domain seems to play a role in the retention of mSec22b in the Golgi-ER system. When the 
amino acids assumed to be involved in the salt-bridge formation were mutated in the SNARE-
motif of mSec22b (D169A, K144D), its localisation was not affected (Fig.15b, C right 
picture).  
In summary, when most of the cytoplasmic tail was deleted, the distribution of Sec20 
remained unchanged, mSec22b accumulated in the Golgi, and finally Use1 reached the 
plasma membrane. This would be consistent with the finding that increasing the length of the 
transmembrane domain of several Golgi- and ER-proteins results in their movement to the 
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plasma membrane [193, 275-277]. Indeed, Use1 transmembrane domain (23AA) is longer 
than that of mSec22b (20AA) which is longer than the transmembrane domain of mSec20 
(17AA). 
 
5.6. Immunoprecipitation of the native retrograde SNARE complex. 
 
To determine whether the four putative retrograde Golgi-ER SNAREs could form a 
complex, rat liver microsomal membranes were extracted with a Triton X-100 containing 
buffer, and appropriate aliquots were used for immunoprecipitation using affinity-purified 
antibodies directed against mUse1, mSec22b, or mSec20, or corresponding pre-immune sera.  
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together with mSec22b as they both participate in the formation of the anterograde ER-Golgi 
SNARE-complex (Fig.16a A). The specificity of the formation of the retrograde SNARE-
complex is further underlined by the observation, that immunoprecipitation with anti-rBet1 
antibodies co-precipitated some mSec22b, but no mSec20, mUse1, or Syntaxin18 (Fig.16 D). 
Moreover only weak FRET signal (NFRET = 0,043 ± 0,019) was measured at the Golgi region 
between rBet1-CFP and mUse1-YFP. The observation that anti-rBet1 co-precipitates 
mSec22b although anti-mSec22b does not coprecipitate rBet1 was also reported by Hay et al. 
when studying the anterograde ER-Golgi SNARE-complex [278].  
To exclude that the SNARE co-immunoprecipitations had arisen from complexes that 
only form after detergent solubilisation and to ensure that the majority of the retrograde 
complex exists in the intact membrane, [35S]-methionine labelled mSec20 (synthetized in a 
cell-free system) was added to the membranes and the usual extraction and 
immunoprecipitation procedures were performed, using anti-mUse1 antibodies.  
 
Fig. 17: The SNARE-complex 
formed by Syntaxin18, mUse1, 
mSec20 and mSec22b exists in 
intact membranes. Rat liver 
microsomal membranes were 
incubated with [35S]-methionine 
labelled mSec20 and solubilised 
with Triton X, simultaneously. 
Affinity-purified antibodies against 
mUse1 or preimmune serum were used for coimmunoprecipitation and the same procedure as described in 
Fig.16 was followed. The nitrocellulose membrane was analysed by autoradiography (A) and subsequently by 
immuno-blot (B).  
A B 
 
Only traces of labelled mSec20 coprecipitated with the non-labeled SNAREs and this 
amount did not exceed the amount precipitated with the preimmune serum (Fig.17 A). In 
these experiments the portion of mSec20 precipitated amounted to 4 % of the total mSec20 in 
the membrane extract (Fig.17 B). These data show that the retrograde SNARE-complex 
demonstrated by co-immunoprecipitation exists before membrane extraction and does not 
form only after membrane solubilisation.  
The role of NSF and α-SNAP is to disassemble some, if not all, SNARE-complexes in 
an ATP-dependent manner, leading to free-SNAREs release. To test their ability to 
disassemble the putational retrograde SNARE-complex, the membrane extracts were 
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incubated with both proteins for 1 h under the conditions given in Fig.18. 
Immunoprecipitation was performed with anti-mUse1 antibodies.  
 
Figure 18: The SNARE-complex formed by 
Syntaxin18, mUse1, mSec20 and mSec22b is 
disassembled by NSF and α-SNAP. Antibodies 
directed against mUse1 were used for co-
immunoprecipitation performed as described in Fig.16. 
The membrane extracts were incubated for 1 h at 16°C 
in the presence (+) or absence (-) of the indicated 
components: NSF (50nM), α-SNAP (2 µM), ATP (5mM), MgCl2 (8mM) and EDTA (2mM). Note that the 
protein concentration given for NSF includes active and inactive NSF. The NSF activity was previously tested 
(by Ulrike Winter) with an in vitro assay following the kinetic of disassembly of the synaptic SNARE-complex 
and found to be active.  
 
When both NSF and α-SNAP are absent from the incubation, Syntaxin18, mSec20 and 
mSec22 were co-immunoprecipitated with mUse1 as observed previously (Fig. 16a B). When 
NSF and α-SNAP are added in presence of EDTA without MgCl2, the same result was 
obtained since EDTA inhibits NSF ATPase activity by chelating divalent cations. In contrast, 
in the presence of ATP and MgCl2 (absence of EDTA), only mUse1 became precipitated 
indicating that the complex had been dissociated by NSF and α-SNAP (Fig. 18).  
 
5.7. Interaction of the SNARE-proteins mUse1, mSec20 and mSec22b with the 
KDEL-receptor Erd2. 
 
ERD2 binds in the Golgi ER-resident proteins which possess a C-terminal KDEL (-
XXEL) motif when they have escaped from the ER, and allows for their back-transport to the 
ER. This required that the occupied KDEL-receptor is sorted into budding retrograde vesicles 
or tubules. Therefore, we have examined whether components of the retrograde SNARE 
complex might interact with Erd2 in single living cells. Vero cells co-expressing Erd2-YFP 
and one of the retrograde SNAREs fused to CFP (mSec22b-CFP (A), mUse1-CFP (B) and 
mSec20-CFP(C)) were analysed by single-cell FRET microscopy (Fig.19).  
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indeed with the different SNAREs of interest. Moreover, in immunoprecipitation experiments 
with rat liver microsomal membranes, antibodies directed against mUse1 co-precipitated Erd2 
(Fig.16 B).  
 
5.8. Presence of the SNARE-proteins in COPI vesicles. 
 
It is generally assumed that COPI-coated transport intermediates, believed to be either 
vesicle
e subunits of the COPI coat, was present in all the Golgi (G1,G2 and 
G3) an
s or tubules, mediate intra-Golgi and Golgi-to-ER retrograde transport. COPI-
dependent retrograde transport has in particular been described to be followed by the occupied 
KDEL-receptors and membrane proteins containing a cytoplasmic C-terminal KKXX motif. 
These reports together with the co-immunoprecipitation experiments and FRET data reported 
here which indicate interactions between Erd2 and the different retrograde SNARE candidates 
suggest that mSec22b, mUse1, mSec20 and Syntaxin18 could be involved in a COPI-
dependent transport from the Golgi to the ERGIC and/or to the ER. To study this issue, Golgi 
stacks were isolated from rat liver and incubated under conditions which allow for vesicle 
release under the indicated conditions (Fig.20 A). Thereafter, the vesicles were isolated and 
their compositions were analysed by western-blotting (Fig.20 A) and by immuno-electron 
microscopy (Fig.20 B).  
β´-COP, one of th
d vesicles (V1, V2 and V3) fractions after incubation. It was found in a larger amount 
in the G2 fraction. Indeed, as GTPγS prevents COPI coat disassembly, the coatomer tended to 
accumulate at the Golgi membrane, whereas for the G3 fraction in presence of GTP the coat 
can be disassembled and released from the vesicles. In case of incubation condition1, neither 
the disassembly nor the assembly of COPI coatomer was stimulated, therefore, most of the β´-
COP subunits stayed in the supernatant (S1, Fig.20 B) as compared to S2 and S3 supernatants. 
Low amounts of ERGIC53 and syntaxin18 were found consistently in the V2 and V3 
fractions. Thus, the IC did not seem to be present in any of the isolated Golgi or vesicles 
fractions. As syntaxin18 was shown to be localized principally in the ER [222], the signal 
observed in the vesicles V2 and V3 fractions can come either from an ER contamination 
during the preparation or a few molecules of syntaxin18 which escaped from the ER and are 
recycled back. KDEL-receptors resided mostly in the Golgi fractions but were also clearly 
present in the vesicle fractions (Fig.20 A). 
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 presence of cytosolic β´-COP protein (B).  The same amounts of total proteins were loaded on a 15% SDS-
l for the Golgi fractions G1, G2, G3 and G, for the Liver sample (100µg) as well as for the samples containing 
sicles V1, V2 and V3 (50µg) (A). For the supernatant fractions S1, S2, S3 and cytosol the same volumes were 
ded on a 12% SDS-gel (B). The fractions contents were analysed for the indicated proteins. 
 
tosol used for Golgi incubation and the supernatants obtained after 
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 but still remained in large amounts in the Golgi suggesting an important sorting of 
Sec22b into the Golgi-derived vesicles. The novel mammalian SNAREs mUse1 and 
Sec20 were found both in the vesicle-fractions while mUse1 was also present in the Golgi, 
Sec20 was almost absent from this compartment. Since these SNARE-proteins seem to exist 
 85 
 Results 
___________________________________________________________________________ 
in a relatively small amount as compare to mSec22b (Fig.20 A and C), they could be sorted 
into Golgi vesicles (most likely retrograde Golgi-ER COPI vesicles) which contain mSec22b.  
The vesicle population obtained after incubation of the Golgi for vesicle release is 
most likely highly heterogeneous meaning that only a small part correspond to Golgi-ER 
retrograde COPI vesicles. Indeed, intra-Golgi COPI vesicles as well as uncoated vesicles or 
undefined coated vesicles can also be found in the fractions. Therefore, the presence of the 
different SNARE-proteins of interest on COPI vesicles was further analysed by immuno-EM 
(Fig.20, C). The existence of mSec22b, mUse1 and mSec20 on COPI vesicles was confirmed 
even though the staining for mSec20 (Fig.20, C) was weak which is in line with the 
immunoblotting experiment (Fig.20, A). Importantly, mSec22b and mUse1 were found on the 
same vesicles, which are most probably COPI vesicles as seen by the specific pattern (thick 
coat) around the vesicles. As expected, KDEL-receptors were quite abundant in COPI-
vesicles.  
 
 Since mUse1 and mSec22b are found within small membrane-enclosed COPI vesicles, 
the possibility that they interact with one of the subunits constituting the COPI coat was tested 
by co-immunoprecipitation using from detergent-extracts V2 and V3 vesicles. 
 
 
 
 
 
A B 
 
Figure 21: Interaction of mUse1 with COPI coatomers. Antibodies directed against mUse1 (A) and mSec22b 
(B) were used for co-immunoprecipitation detergent extracts of from V2- and V3- Golgi-derived vesicles and 
experiments were performed as described in the legend to Fig.16. V2 and V3 are vesicles obtained from the 
Golgi as described in the legend to Fig.20. Fractions were separated by 12% SDS-PAGE and analyzed by 
immunoblotting using antibodies against β´-COP, mUse1 and mSec22b. The unbound loaded fraction 
corresponds to 5% of the total unbound proteins. 
 
 When mUse1 was used as target protein, a significant amount of β´-COP was detected 
in the V2-precipitate but only traces in the V3-precipitate. No coprecipitation of mSec22b was 
found in extracts from V2-vesicles and only a very weak signal for mSec22b was obtained in 
the V3-vesicle precipitate. mSec22b antibodies did not precipitate β´-COP but some mUse1 
could be detected in precipitates from V2- and V3-fractions. All together these data suggest 
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that mUse1 interacts with components of the coat in COPI coated vesicles whereas mSec22b 
does not, even when the coatomers are abundant on the vesicles (V2 sample). As anti-mUse1 
antibodies coprecipitated β´-COP under conditions where almost no mSec22b was 
coprecipitated, it appears that the free mUse1, rather than mUSE1 present in SNARE-
complexes, was interacting with β´-COP. 
 
5.9. Effects of down-regulation of mSec22b, mUse1, or mSec20. 
 
If these SNAREs are involved in Golgi-ER retrograde transport, one should expect 
that down-regulation of their expression might impair cargo translocation from the Golgi to 
the ER, although one has to consider the possibility that structurally related SNARE-proteins 
mainly involved in other transport steps could functionally compensate for the loss. Cholera 
toxin is a retrograde cargo which is, via the interaction of its B-subunits with the plasma 
membrane ganglioside, endocytosed and transported to the Golgi, where its A-subunit, which 
possesses a C-terminal KDEL-signal, interacts with the KDEL-receptor Erd2 and becomes 
translocated by retrograde transport to the ER. Therefore, mSec22b was down-regulated in 
Vero cells by transfection with an appropriate siRNA for 72 h and cholera toxin was 
subsequently applied to the cells.  
The amount of Sec22 protein in sham-transfected cells (siRNA GL2) and in the 
siRNA Sec22 transfected cells was estimated by western-blotting (Fig. 22a, A). 72 hours after 
transfection about 90% of the endogenous mSec22b has disappeared in the siRNA Sec22 
transfected cells whereas no effect was observed in sham treated-cells. In both cases, no effect 
on Use1 expression was observed.   
In sham-transfected cells, CTX-A had accumulated in the ER 120 min after start of 
CTX uptake (Fig.22a, B left panel). In mSec22b-downregulated cells, the toxin did not reach 
the ER but instead accumulated in perinuclear punctuated structures (Fig.22a, B right panel). 
This suggests that the CTX transport is disturbed when mSec22b becomes quasi depleted 
from the cells.  
Donwregulation of mSec20 or mUse1 did not give meaningful results as far as 
retrograde transport of CTX is concerned, as in both cases, down-regulation was associated 
with severe disturbances of intracellular membrane organization (Fig.22b, A and B), which in 
the case of mSec20 down regulation was frequently associated with cell death. A similar 
observation has recently reported by Nakajima et al. [226] for down-regulation of the human 
mSec20 ortholog. 
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6. DISCUSSION 
 
In this work, I have shown that in mammalian cells mSec22b and Syntaxin18 can form a 
SNARE-complex with the novel SNARE-proteins mSec20 and mUse1, which is most likely 
involved in retrograde Golgi-(ERGIC)-ER transport. Live cell FRET and BiFC measurements 
as well as co-immunoprecipitation indicated that these SNARE-proteins interact with each 
other and with components of the retrograde transport machinery. The function of mSec22b, 
mSec20, and mUse1 was further demonstrated in cells where their expression was down-
regulated using siRNA.  
 
6.1. Characterisation of a new mammalian SNARE-complex 
 
According to the alignment of SNARE motif sequences (Fig. 9A), the zero layer of the 
new mammalian SNARE-complex described here is composed of one arginine, one 
glutamine, one serine, and one aspartate (1R-1Q-1S-1D). This differs from most other known 
SNARE-complexes where the zero layer is composed of one arginine and three glutamines 
(1R-3Q). Other SNARE-complexes also possess a zero layer where one of the “Q-SNAREs” 
is a serine or an aspartate instead of a glutamate [83-85]. The presence of both serine and 
aspartate residues in the zero layer should not induce strong changes in the complex structure 
as both are polar residues and can form hydrogen bonds with the side chain of the R-SNARE 
mSec22b (Fig. 9B). When taking a closer look at the novel mammalian SNARE-protein 
mSec20, its SNARE motif sequence is only weakly related to that of other known mammalian 
SNAREs; also, it and shows only 15% homology (8% identity) with its yeast homolog 
Sec20p. Even though this retrograde Golgi-ER SNARE-complex does not follow the “1R-3Q 
rule” previously defined for other SNARE-complexes, its formation depends on the presence 
of the SNARE-motif as shown by the results of the BiFC experiments (Fig. 15a). Here, 
deletion of the mUse1 SNARE motif revealed that the SNARE motif is essential for SNARE 
pairing. This had previously been observed in yeast for Sec22p where the SNARE motif 
deletion mutants failed to assemble into SNARE complexes [279]. Even the mutation of only 
two amino acids within the mSec22b SNARE motif already induced a decrease of its 
interaction with mUse1 (Fig.15a, D). Similar to other SNARE-complexes, the retrograde 
SNARE-complex described here can be disassembled by NSF and α-SNAP (Fig.18). 
Altogether, these observations both show that the four proteins studied in this work form a 
new SNARE-complex which has similar and different features to classical synaptic SNARE-
complex. It would be interesting to perform structural studies with  the individual proteins 
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mUse1 and mSec20 since they appear to be unusual SNAREs. It would also be of interest to 
know more about the biochemical and structural features of the complex they form with 
mSec22b and Syntaxin18. 
 
6.2. Distribution of the retrograde Golgi-ER SNARE-proteins  
 
The steady state distribution of the four retrograde Golgi-ER SNARE-proteins is different 
throughout the cell. The R-SNARE mSec22b is mainly present in the Golgi and in the 
ERGIC, but can also be found at lower concentrations in the ER. The Q-SNAREs (mUse1, 
mSec20 and Syntaxin18) are differently distributed between these three compartments. 
mUse1 is mostly found in the ER, the same holds for Syntaxin18 [222]. Nevertheless, mUse1 
was also consistently found in the ERGIC and in lower concentrations in the Golgi. 
Interestingly, mSec20 was evenly distributed between the Golgi and the ER but was also 
found in the ERGIC at a very low concentration. The dispersed punctuated structures 
observed for mSec20 may correspond to the ER exit sites. This could be further studied using 
proper antibodies against Sec13 or Sec31. According to the distribution of the different 
individual SNAREs, the most probable scenario is that mSec22b is the v-SNARE present on 
the vesicle which buds from the Golgi or from the ERGIC. The vesicle is then transported to 
the ER where mSec22b can form a SNARE complex with three ER-t-SNAREs, which could 
be mUse1, mSec20 and Syntaxin18. mSec22b being the R-SNARE in both anterograde and 
retrograde transport, the retrograde complex could be disassembled by NSF/α-SNAP and the 
free mSec22b could be recycled to the ERGIC or the Golgi where it could either become part 
of the anterograde SNARE-complex with Syntaxin5, membrin and rBet1 or be involved in  
another retrograde transport fusion event. mSec22b could also play the role of a v-SNARE for 
Golgi-to-ERGIC transport and form a SNARE-complex with mUse1 and two other Q-
SNAREs which would be localized in the ERGIC. It has to be further analysed whether one 
of these Q-SNAREs could be syntaxin18. Alternatively, the v-SNARE for the retrograde 
transport could also be mUse1 as it is significantly expressed in the ERGIC (also suggested in 
the review [80]). Moreover, anti-mUse1 antibodies precipitate β´-COP even though mUse1 is 
only present at a low concentration in the Golgi (Figures 12 and 20;see below). Finally, one 
cannot exclude the existence of unknown SNARE-proteins and, therefore, of other SNARE 
complexes in the Golgi-ERGIC-ER system.  
According to the results obtained with the cell–free Golgi budding assay, mSec22b and 
mUse1 were strongly enriched in the Golgi-derived vesicles, while mSec20, which is weakly 
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present in the Golgi, was almost completely sorted into the vesicles (Fig.20, A and C). 
Moreover, the majority of the vesicle populations must have been released from the Golgi 
stacks, as ERGIC was not present in the Golgi fractions (Fig. 20A). These data suggest that 
mSec22b and mUse1 are actively sorted from the Golgi into vesicles and that mSec20 and 
syntaxin18 escaped from the ER and cycle between the ER, the ERGIC and the Golgi and 
need to be retrieved back to the ER probably in the same vesicles which contain both, 
mSec22b and mUse1 (Fig. 20C). 
FRET data obtained in live single cells showed interactions between the fluorescent fusion 
proteins of mSec22b, mSec20 and mUse1 (Fig.14b). So far, similar experiments using 
syntaxin 18 with the fluorophore linked to its N-terminus did not give reliable results, so that 
the demonstration of a participation of syntaxin18 in the Golgi-ER SNARE-complex in intact 
mammalian cells needs further experimentation. The BiFC experiments confirm the results of 
the FRET-experiments. Moreover, BiFC experiments using mSec20 deleted for its SNARE 
motif underline the specificity of the interactions of mSec20 with mUse1 and mSec22b, and 
exclude that the interactions involve mainly transmembrane domains or are simply stochastic 
phenomena resulting from “membrane crowding” (Fig.15a). Additionally, FRET results 
showed that the interactions between the different SNAREs occur mainly at the periphery of 
the cell, which most likely represents the ER and ER exit sites, and perhaps includes parts of 
the ERGIC (Fig.14d, D).  
This observation is in line with the localisation of mSec22b, mSec20 and mUse1 (Fig.12) 
and with the previous suggestions concerning a role for the studied SNARE-complex in 
ERGIC to ER retrograde transport. One should point out that the distinction between regions 
in the cell where the proteins interact or not can only be made if the FRET raw data are 
normalized by the expression levels of the SNARE-fusion proteins. The method of 
calculations of  NFRET (see methods) allows for such a distinction.  
The only SNARE-pair for which a FRET signal could be measured in the perinuclear 
region is mSec22b-mSec20 (Fig.14d, D). This region includes most likely the Golgi and 
partially the ERGIC. These data are in agreement with the intracellular localisation of the two 
SNAREs and suggest that, since mSec20 is in the Golgi and not in the ERGIC (Fig.12), 
mSec20 could interact with mSec22b to form a “binary SNARE-complex” which would be 
transported directly to the ER where it could form a quaternary SNARE-complex with 
Syntaxin 18 and mUse1 or other SNAREs. mSec22b would additionally be guided to the 
ERGIC in vesicles containing mUse1 as observed with immuno-EM (Fig. 20). In this context, 
it would be interesting to see whether the different combinations (1R-3Q, 1R1Q-2Q…) can 
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form a SNARE-complex by using the approach of a reconstituted proteoliposome fusion 
assay [280].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Distribution of the retrograde Golgi-ER SNARE-proteins within the Golgi-ERGIC-ER system.  
The scheme depicts the Golgi, the ERGIC and the ER. Arrows indicate retrograde and anterograde transport 
steps and the dashed arrow indicates the putative COPI-independent pathway between the TGN and the ER. 
Colors show  coatomers : Clathrin (orange), COPII (blue) and COPI (red). The concentration of the SNARE-
proteins differ between the three organelles. This is shown by the font size (small, medium and large) used to 
indicate the name of the different SNAREs mSec22b (S22), mUse1 (U), mSec20 (S20)and syntaxin18 (S18). 
 
6.3. Role of the Golgi-ER retrograde SNARE-proteins in the COPI-dependent  
pathway 
 
Coimmunoprecipitations of  detergent extracts from Golgi-derived vesicles show that 
β’COP can be co-precipitated with mUse1 but not with mSec22b. Moreover, in the same 
experiment, antibodies against mUse1 which co-precipitated the β´-COP subunit did not co-
precipitate mSec22b, while mSec22b antibodies which did not co-precipitate β´-COP co-
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precipitated mUse1. Interestingly, Mossessova et al. [111]have recently described a set of 
interactions between COPII and ER–Golgi SNAREs, involving discrete peptide sequences of 
10–15 residues which could function as signals for ER export. COPII discriminated between 
the free and the complexed forms of Bet1 by binding a motif (LxxLE) buried in the N-
terminal region of the v-/t-SNARE helical bundle and only available in the unstructured free 
v-SNARE. The authors designate this mechanism of coat selectivity as “v-SNARE 
conduction”, to convey the notion that this specific recognition process causes the sorting of 
the v-SNARE from the donor membrane into the vesicles. Miller et al. [110]and Liu et 
al.[279] demonstrated that in yeast at least two separate sites were necessary for optimal 
packaging of Sec22p into COPII vesicles : (1) the N-terminal domain, (2) the 10 amino acid 
residues between the -4 and -1 layers of the SNARE motif. Liu et al suggested that these 
anterograde SNARE proteins (i.e. Bos1p, Sed5p, and Bet1p) were transported individually 
[92], although this result does not rule out the possibility that Bos1p, Sed5p, and Bet1p exit 
the ER in a ternary SNARE complex. As far as the mammalian ER/Golgi SNARE proteins 
are concerned, heteromeric SNARE interactions are not required at any step in rbet1 targeting 
or transport dynamics [107]. Moreover, antibodies against the mammalian ER/Golgi SNARE 
proteins (i.e. syntaxin5, membrin, mSec22b, and rbet1) blocked the recruitment of these 
individual SNARE proteins into COPII vesicles without any effect on the packaging of the 
other SNARE proteins [107, 181]. Therefore, the trafficking of ER/Golgi SNARE proteins 
from the ER in unassembled states seems to represent a general mechanism conserved from 
yeast to mammals. According to our results obtained with Golgi-derived vesicles in vitro, 
mUse1 could be the v-SNARE which interacts with the COPI coat. mSec22b, via its 
interaction with mUse1, would be directed into COPI vesicles and retrieved back to the ER 
where the quaternary SNARE-fusion complex could be formed with mSec20 and Syntaxin18. 
Nevertheless, more information concerning interactions between retrograde SNAREs and 
COPI subunits is needed. Moreover, we cannot exclude the possibility that the anti-mSec22b 
antibodies used in our experiments do not allow β’COP binding to mSec22b. It would be 
interesting to know whether other COPI subunits (α,β,γ,δ,ε and ζ) can also be precipitated 
with these antibodies. It has been described that COPII selectivity involves conformation as 
well as sequence determinants on Sed5 [279]. This could also hold for syntaxin18 in view of 
the well-documented conformational switching of syntaxin SNAREs (for review see [281]). 
Interestingly, Sec22p may exit the ER as part of the t-SNARE complex or as a monomer 
interacting with Sec23/24 [111]. This implies that the ER-to-Golgi SNARE-complex does not 
need to be disassembled by NSF/α-SNAP in order to provide mSec22b for the retrograde 
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Golgi-to-ER SNARE-complex. mSec22b, which arrives as monomer in the Golgi, could be 
used directly for retrograde transport and the pool of mSec22b which was involved in the 
anterograde complex can be recycled back from the cis-golgi or from the ERGIC to the ER 
using COPI dependent or independent pathways. In the ER, it can either form a SNARE 
complex with the other three retrograde Golgi-ER SNARE-proteins or form a “new” t-
SNARE complex with Bos1 (membrin) and Sed5p (syntaxin5). This could also explain the 
steady state distribution of mSec22b in the Golgi.  
Mossessova et al. [111] proposed that the directionality imposed by the coat 
assembly/disassembly cycle may control fusion of vesicles moving anterogradely, while 
preventing fusion of COPII vesicles back to the ER (because COPII binds fusogenic SNAREs 
at the originating membrane). This view cannot be directly applied to COPI vesicles, as COPI 
coated vesicles are known to be involved in Golgi-ER and intra-Golgi retrograde transport as 
well as in forward intra-Golgi transport steps. Other additional factors must be involved to 
direct the COPI vesicles and their contents in one or the other direction. The mechanisms 
which regulate whether a COPI-coated transport vesicle moves forward or backward are 
unknown at present. Several scenarios could be considered such as the existence of distinct 
but related populations of coatomers: one for anterograde, the other for retrograde transport. 
Another possibility is that coatomers might only be involved in vesicle-mediated transport 
only in the retrograde direction. Two alternative mechanisms have been proposed for 
anterograde intra-Golgi transport: first, the existence of a set of still unknown coat proteins 
and second, the formation of tubular extensions that emanate from one Golgi cisternae and 
fuse with an adjacent cisternae [214]. In this concept anterograde transport would be mediated 
by tubules rather than by vesicles. An alternative could be that the direction depends on the 
nature of SNARE-proteins present on the vesicle. Clathrin-coated vesicles also move along 
different pathways (Fig.1). This is regulated by the existence of different types of coats 
mainly due to the different adaptor proteins AP1, AP2, and AP3. In the same way, COPI-
coated vesicles might contain some proteins which could play a role as guides for the vesicles; 
the SNARE-proteins are good candidates for such a role. Indeed, their localization throughout 
the cell is specific for one or two compartments between which they circulate. Interestingly, 
Lanoix et al. [53]have previously described the existence of more than one population of 
COPI vesicle involved in the intra-Golgi transport; at least one containing Mann II/GS28  (a 
medial–trans Golgi enzyme and a Golgi SNARE-protein) and another one in which the four 
p24 proteins, 2, ß1, 1, and 3, were found. None of them contained significant amounts of 
anterograde cargo. This is in favour of a two-step intra-Golgi pathway, the first for the CGN 
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to cis cisterna, the second for the later medial and trans Golgi compartments. Recently, 
Malsam et al.[213] also described the presence of 2 distinct subpopulations of COPI vesicles: 
one having a role in intra-Golgi transport containing Golgi enzymes, and the other containing 
the proteins of the transport machinery retrieving them back to the ER. They suggest a two-
step retrograde pathway for the Golgi enzymes, the first step mediated by intra-Golgi COPI 
transport to the cis-Golgi Network (CGN), the second by a COPI-independent pathway to the 
ER. All these observations show the diversity of COPI vesicles which could be classified 
depending on their contents. It would be interesting to study whether these COPI vesicles can 
also be distinguished with respect to their composition of SNARE-proteins. Although we 
could observe by EM that most of the Golgi-derived vesicles are COPI-coated, we cannot 
exclude the presence of other vesicles. Indeed, a COPI-independent pathway has been 
suggested for the retrograde Golgi-ER transport [210]. In case these vesicles would contain 
some of our SNAREs, this would favour the idea that a certain set of SNARE-proteins is 
specific for one direction of transport between two compartments in a cell rather than specific 
for only one type of coat.  
 
Despite the conserved structure and function of the SNARE domain, the N-terminal 
domain of distinct SNARE proteins appears to be divergent in both structure and function. 
This is also true for the newly characterised Golgi-ER retrograde SNARE-proteins. Indeed, 
the truncation of the N-terminal portion (including the SNARE motif) of mUse1 led to its 
transport to the plasma membrane, whereas in case of mSec20 a N-terminal truncation did not 
affect the ER localisation of the protein (Fig. 15b). Moreover, when only the SNARE motif 
was deleted in mUse1, its localisation remained unchanged as compared to the wt-protein. N-
terminal regions in mUse1 and other SNARE proteins [132, 133, 282, 283] are required for 
their proper intracellular targeting. It seems probable that signals within these regions will 
interact with specific coat protein complexes. Such interactions are likely to govern 
intracellular location and therefore contribute to the fidelity of membrane fusion reactions. 
Indeed, SNARE protein localization may play a significant role in specifying membrane 
fusion partners.  
In my experiments, antibodies against rBet1 precipitated mSec22b but not mUse1 or 
mSec20. Moreover, none of the antibodies raised against the three retrograde SNARE-
proteins precipitated rBet1. This suggests that rBet1 is involved only in the anterograde 
transport but not in the Golgi to ER retrograde transport and underlines further the existence 
of two distinct pathways with opposite directions between the two compartments, involving at 
  95 
  
Discussion 
___________________________________________________________________________ 
least partially specific SNARE proteins. Nevertheless, rBet1 must slowly recycle back to the 
ER, which would explain why a weak FRET signal could be measured between mUse1-YFP 
and rBet1-CFP in the Golgi region (see page 75). 
 
In the Golgi-ER retrograde pathway, sorting of membrane proteins occurs through the 
interaction of their cytoplasmic domains with coat proteins. Such membrane proteins typically 
bear ER retrieval signal such as a dilysine (KKXX) motif at their C-terminus. Although the 
KDEL receptor lacks such a signal, it is well established that it is transported from the Golgi 
complex to the ER in COPI coated transport intermediates [158, 206, 210]. Therefore, other 
factors different from the classic dilysine retrieval motif must be responsible for the 
interaction of the C-terminal domain of the KDEL receptor with coatomer proteins. Cabrera et 
al. [208] suggest that phosphorylation of serine 209 promotes the interaction of the KDEL 
receptor with both coatomer proteins and ARF-GAP. Interestingly, I observed that the KDEL 
receptor interacts with mUse1 (Fig.16). This underlines our findings concerning the binding 
of mUse1 to the COPI coat. The interaction occurring between the KDEL-receptor and 
retrograde Golgi-ER SNARE- proteins was further confirmed by live cell microscopy data 
which showed that mUse1-CFP but also mSec22b-CFP and mSec20-CFP interact with Erd2-
YFP in the cell periphery. This indicates that SNARE proteins may be involved in the 
formation of a sorting/budding complex at the donor compartment.  According to the 
localization of the measured FRET signal between Erd2 and the different SNAREs of interest, 
this compartment would most likely correspond to the ERGIC as no significant FRET signal 
was measured in the perinuclear region of the cell. 
 
Down-regulation of mSec22b blocked the accumulation of CTX in the ER but led to the 
accumulation of CTX in punctuated structures which need to be further characterized. Their 
perinuclear distribution suggests that these structures could be partially Golgi and/or ERGIC. 
We cannot exclude that the down-regulation of mSec22b also affects the ER-Golgi 
anterograde transport. This could lead to a lack of transport from ER to Golgi of the 
components of the retrograde transport machinery and, therefore, affect also CTX transport. 
To study the anterograde transport in the mSec22b depleted cells, VSVG-GFP could be used 
as a marker for the secretory pathway. The other possibility would be that down-regulation of 
mSec22b induces up-regulation of another R-SNARE such as the partially soluble Ykt6 
which could compensate for the transport defect. Indeed, the multicomponent character of the 
coated-vesicle-based pathways frequently allows compensation sometimes to the extent that 
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only a weak cellular phenotype becomes manifest, even in a multiple knockout. Ykt6p is i
partially soluble and this may enable it to substitute for other R-SNAREs in multiple fusion 
reactions. This could explain why deletions of several yeast R-SNAREs have surprisingly 
mild phenotypes [92]. The same could hold for mammalian cells, as in the experiments 
reported here down-regulation of mSec22b did not lead to such dramatic changes in the 
cellular state as observed for the Q-SNAREs mSec20 and mUse1. This compensation of a low 
mSec22b expression level by Ykt6 could affect the anterograde ER-to-Golgi COPII and the 
intra-Golgi COPI pathways selectively. It was previously shown in yeast that when the level 
of the Golgi/endosomal SNARE protein Ykt6p is elevated on COPII vesicles in the absence 
of Sec22p, it assembles into an ER/Golgi SNARE complex and can function with non-
cognate SNAREs in the fusion of ER-derived vesicles with the Golgi complex [92]. 
Moreover, Ykt6 is known to be part of the forward intra-golgi SNARE-complex. It could be 
that Ykt6 does not or only partially compensate for mSec22b in its role in the retrograde 
SNARE-complex. This would explain why the morphology of the cell is not affected when 
mSec22b is down-regulated (Fig.22b) while CTX transport is perturbed as indicated by its 
retention in punctuated structures and by the lack of further transport into the ER.  
Down-regulation of mSec20 or mUse1 in Vero cells led to morphological changes of the 
cell and to a defect in growth/proliferation. These changes could result from the loss of 
functions which may not be related to SNARE-complex formation and fusion. Indeed, beside 
its role as a SNARE-protein, mSec20 belongs to the family of BH3-only proteins which are 
involved in the regulation of apoptosis. This might explain the dramatic effects of its down-
regulation. 
 
6.4. Golgi-to-ER retrograde pathways 
 
Several independent lines of evidence indicate that retrograde transport from the Golgi 
apparatus to the ER may be mediated by COP-I-coated vesicles. COP-I interacts with retrieval 
motifs of membrane proteins that are known to recycle between the ER and the Golgi 
apparatus [48]. In yeast strains in which COP-I is mutated and unable to bind retrieval motifs, 
reporter proteins containing such motifs escape the secretory pathway to the plasma 
membrane [149, 284]. Furthermore, antibodies to COP-I block the relocation of Golgi 
enzymes to the ER in the presence of brefeldin A (BFA) [285], which disrupts the Golgi, and 
transport of cholera toxin from the Golgi to the ER requires COP-I function [206].  
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Girod et al. [210]demonstrated the existence of at least one Golgi-to-ER recycling 
pathway that is COP-I independent and appears to be regulated by the small GTPase Rab6. 
This transport was shown to be followed by labelled Shiga toxin B-fragment (The shiga toxin 
belongs to the AB -toxin family as the cholera toxin) and the Golgi-resident glycosylation 
enzyme GalNAc-T2. 
5
Thus, there are at least two general transport pathways from Golgi to 
ER. One requires binding to the KDEL-receptor ERD2 in the Golgi apparatus and follow the 
COPI-dependent pathway and the other would follow the COPI-independent pathway.  
The COP-I-independent recycling pathway described by Girod et al. could work at the 
level of the cis-Golgi network, where it would help to return molecules back to the ER 
alongside the COPI-dependent Golgi-to-ER recycling pathway. An alternative would be that 
the COPI-independent transport emanates from the TGN and reaches the ER directly.  Indeed, 
a modified version of the Shiga toxin B-fragment engineered to contain a site for modification 
by N-linked oligosaccharides, a site for tyrosine sulphation and a KDEL signal showed that 
sulphation precedes addition of N-linked core glycosylation [286]. As sulphation occurs in the 
TGN and N-linked core glycosylation takes place exclusively in the ER, the Shiga toxin B-
fragment must reach the TGN but does not need to pursue its route to the medial and cis 
cisternae before reaching the ER. In this context, it would be useful to apply live cell 4Pi 
microscopy, a high resolution light microscope which allows to distinguish between the 
different Golgi cisternae (Verrier, S. et al., work in progress) and follow the Shiga toxin route 
using appropriate Golgi markers.  
Girod et al. suggested that the main function of the observed COP-I-independent recycling 
pathway might be to recycle lipids. A portion of the lipids which reaches the TGN are 
predicted to move forward via vesicles to the plasma membrane or into the endocytic 
pathway, but a significant proportion would remain. Recycling of these remaining lipids back 
to the ER would then ensure the overall balance of the pathway. This would be in accordance 
with both of the highly discussed models: the cisternal maturation model and the vesicular 
transport model. The first one predicts that anterograde cargo remains in Golgi cisternal 
membranes and that cisternae mature in a cis-to-trans direction, whereas resident proteins 
move in the opposite direction via COPI vesicles and in the second one, each cisternae instead 
constitutes a stable compartment, and anterograde cargo move via COPI anterograde vesicles 
from cisterna to cisterna in a cis-to-trans direction.  
The mechanisms of retrograde trafficking are likely to be highly regulated [12, 134, 287] 
and to involve lipid partitioning to segregate recycling components from forward moving 
cargo [193]. Indeed, certain lipids (e.g., glycosphingolipids and cholesterol) may help to 
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partition proteins into specific membrane domains [288] while others (e.g., 
phosphoinositides) can regulate the membrane recruitment of clathrin coats and of other 
trafficking components [289, 290]. This may hold as well for the COPI recruitment at the 
Golgi and ERGIC membranes. Other factors are likely to be identified, such as motor 
molecules and their regulators that could be recruited to the membrane-microtubule interface 
to guide the retrograde transport carriers (as proposed by Duran et al.[291]). 
 
6.5. Perspectives for a better understanding of intracellular trafficking 
 
Upon arrival at the cis-Golgi, anterograde cargo must physically segregate from 
retrograde cargo in order to be delivered for further transit through the secretory pathway, 
whereas retrograde cargo must be returned back to the ER. The mechanism by which this is 
achieved cannot yet be revealed by time-lapse microscopy of GFP-tagged markers, due to the 
lack of appropriate retrograde transport markers and the limits of resolution of light 
microscopy. The best characterized transport intermediates are indeed small, spherical coated 
vesicles. But emerging evidence from mammalian cells points to an additional form of 
transport by large pleiomorphic intermediates[42]. A well-documented example of such a 
transport intermediate are the COPI-containing VTCs that move from ER exit sites to the 
Golgi complex [165, 292, 293]. Using current light microscopy techniques, small 60-80 nm 
vesicles cannot be seen in living cells. Many of the structures observed so far could represent 
vesicle populations, which might even be tethered one to another and, therefore appear as a 
pleiomorphic transport complex. Correlated analyses using light and electron microscopy on 
the same cell [38] could be one way to resolve these questions. Perhaps one limitation is that 
usually the GFP-tagged molecule is ectopically expressed in a system already containing a 
background of the untagged endogenous protein. Ideally one would like to examine these 
GFP-tagged markers by using regulated expression systems in a null background. It seems 
likely that the availability of further spectral variants of GFP, together with developments in 
light microscopy [274, 294]Klar et al., 2000), will facilitate the greater use of light 
microscopy in the analysis of intracellular membrane traffic. Fast-acquisition systems would 
also much improve our ability to analyse the dynamics of vesicular traffic inside living cells. 
The new technical developments mentioned in combination with FRET or BiFC 
measurements will certainly enhance our understanding of the mechanisms involved in 
different pathways. 
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ANNEX I: Principle of FRET 
 
The donor probe D is a fluorescent 
molecule. When light excites D at 
an appropriate wavelength (250-500 
nm) its electrons jump from the 
ground state (S0) to a higher 
vibrational level (S1, S2, S3, etc). 
Within picoseconds these electrons 
decay to the lowest of these 
vibrational levels (S1) and then 
decay more slowly (nsec) to one of 
the S0 states and a photon is emitted 
whose wavelength is longer than the exciting wavelength. 
When the conditions are favorable for energy transfer to occur and the donor probe is excited 
at the appropriate wavelength, decay of donor fluorescence and energy transfer to the acceptor 
will compete for the decay of the excitation energy and can be described by the following 
scheme:    
 D : donor probe  
 A : acceptor probe 
 kd : radiative decay of D without A 
 ka : radiative decay of A 
 kt : rate of energy transfer 
(radiationless) 
 hve : photon energies of D excitation 
(from Van der Meer et al., 1994) 
 
hvd : photon energies of the D fluorescence 
hva : photon energies of A fluorescence 
kdi and kai are radiationless decay constants. 
 The transfer rate kt varies inversely with the 6th power of the donor-acceptor separation (r6) 
over the range of 1-7 nm, such distances are relevant for most biomolecules or their 
constituent domains engaged in complex formation and conformational transition.  
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The transfer rate also depends on J, the overlap integral of the donor emission and acceptor 
absorption spectra, k2, the relative orientation of the donor absorption and acceptor transitions 
moments (range 0-4); and  n, the refractive index (range 1,3-1,6). 
 
Donor quantum yield (Q) is defined as the ratio of the number of photons emitted to the 
number of photons absorbed, a parameter which depends on the immediate environment of 
the probe. In the presence of transfer (Qda) and in the absence of transfer (Qd) we have: 
 
 
 
FRET efficiency (E) can be obtained by measuring the fluorescence intensities of the donor 
with acceptor (Qda) and without acceptor (Qd) 
   
 
It can also be measured using the lifetime of the donor in presence (Tda) and absence of the 
acceptor probe (Td)                                        
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where and   
 
Förster distance 
The relationship between the transfer efficiency (E) and the distance between the two probes 
(R) is given by the equation:                                       
 
 
Ro is the Förster distance between the donor and acceptor probe at which E is 50%.  
There is a limited range of D-A distances which can be probed by any donor-acceptor pair. 
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Qd: quantum yield of D, 
 n: medium refractive index  
(Range 1.33-1.6)   
Nav: Avogadro's number (Nav= 6.02 x 10     per 
mole), 
 κ: orientation factor  
 J: overlap integral  
(from Van der Meer et al., 1994).  
 
 
The overlap integral J represents the degree of overlap between the donor fluorescence 
spectrum and the acceptor absorption spectrum and is given by   
 
 λ : wavelength of the light 
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 εA (λ) : molar extinction coefficient of A at λ 
   fd (λ) : fluorescence spectrum of D normalized on the   
    wavelength scale.                                         
 
 where Fdλ(λ) is the D fluorescence per unit wavelength interval 
 
 
Kappa square, the orientation factor is defined as   
 
 
 
θt : angle between the donor emission transition moment and the acceptor absorption 
transition moment 
θD and θA : angles between the donor-acceptor connection line and the donor emission and 
the acceptor absorption transition moments, respectively 
κ2 varies between 0 and 4. It assumes a numerical value of 2/3 provided that both probes can 
undergo unrestricted isotropic motion.   
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ANNEX II: FRET corrections 
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Figure Annex II: Spectra used for background and bleedthrough corrections. Suspensions of non 
transfected Vero cells (A and B) or Vero cells expressing either GFP2 (C and D) or venusYFP (E and F) were 
excited at 390 nm (left panel: A, C and E) and subsequently at 498 nm (right panel: B, D and F), the excitation 
wavelengths for GFP2 and venusYFP respectively. Emission spectra were acquired before (blue line) and after 
(red line) acceptor photobleaching. The spectra obtained were used to calculate the background and the 
bleedthrough with the programs Origin and Excel. 
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Annex I : Principle of FRET 
 
The donor probe D is a 
fluorescent molecule. When 
light excites D at an appropriate 
wavelength (250-500 nm) its 
electrons jump from the ground 
state (S0) to a higher 
vibrational level (S1, S2, S3, 
etc). Within picoseconds these 
electrons decay to the lowest of 
these vibrational levels (S1) 
and then decay more slowly 
(nsec) to one of the S0 states and a photon of light is emitted whose wavelength is longer 
than the exciting wavelength. 
When the conditions are favorable for energy transfer to occur and the donor probe is 
excited at the appropriate wavelength, decay of donor fluorescence and energy transfer to 
the acceptor will compete for the decay of the excitation energy and can be described by 
the following scheme:    
 D : donor probe  
 A : acceptor probe 
 Kd : radiative decay of D without A
 Ka
 
 : radiative decay of A 
 
ergies of D 
er Meer et al., 1994) 
orescence 
tants. 
 Kt : rate of energy transfer
(radiationless) 
 hve : photon en
excitation 
(from Van d
hvd : photon energies of the D flu
hva : photon energies of A fluorescence 
Kdi and Kai are radiationless decay cons
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 The transfer rate kt varies inversely with the 6th power of the donor-acceptor separation 
n and 
onor quantum yield (Q) is defined as the ratio of the number of photons emitted to the 
RET efficiency (E) can be obtained by measuring the fluorescence intensities of the 
 
It can also be measured using the Tda) and absence of 
where and   
 
etween the transfer efficiency (E) and the distance between the two 
 
Ro is the Förster distance between th r probe at which E is 50%.  
ptor 
(r6) over the range of 1-7 nm, such distances are relevant for most biomolecules or their 
constituent domains engaged in complex formation and conformational transition.  
The transfer rate also depends on J, the overlap integral of the donor emissio
acceptor absorption spectra, k2, the relative orientation of the donor absorption and 
acceptor transitions moments (range 0-4); and  n, the refractive index (range 1,3-1,6). 
 
D
number absorbed a parameter which depends on the immediate environment of the probe. 
In the presence of transfer (Qda) and in the absence of transfer (Qd) we have: 
 
 
 
F
donor with acceptor (Qda) and without acceptor (Qd) 
   
lifetime of the donor in presence (
the acceptor probe (Td)                                        
 
Förster distance 
The relationship b
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